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 Abstract 
 
 
 Problem:  Transitioning patients diagnosed with a mental health disorder from 
inpatient care to outpatient services is a vulnerable time period for treatment adherence, 
safety planning, and mental health outcomes.  Lack of community linkage support, 
mental health stigma, and medical co-morbidity contribute to the patient’s inability to 
safely and effectively transition to a healthy life.  Evidence demonstrates that the role of 
the Advanced Practice Registered Nurse (APRN) in transitioning care for medically 
complex clients from inpatient to outpatient services improves treatment adherence and 
reduces the need for hospital readmission.  However, a gap in science exists with how the 
role of the psychiatric APRN can improve mental health patient transition. 
 Methods:  A two- group randomized, controlled pilot trial assessed the feasibility, 
acceptability and preliminary effects of utilizing a psychiatric APRN to bridge adult 
inpatient to outpatient care for 30 days post-discharge via face to face and telephone 
communication appointments.  Following consent, 48 participants, participated in the 
study and were randomly assigned to either the intervention or treatment as usual group.  
Outcome measures included: (a) first outpatient appointment adherence, (b) 30-day 
hospital readmission, (c) direct and indirect costs related to hospitalization, and (d) 
participant quality of life. 
 Findings:  The APRN Bridge program is feasible to administer in settings that 
have inpatient care and APRNs who are available to follow patients post-discharge.  
iii 
Analysis of acceptability of the intervention when delivered through telephone follow-up 
identified limitations and is an area for future technology considerations. A clinically 
significant (not statistically significant) higher proportion of the intervention group 
attended their first outpatient appointment.    Thirty-day hospital readmissions and costs 
were significantly higher for the intervention group than the treatment as usual group.    
However, participants who had a 80% or greater compliance with the phone intervention 
showed a 6% lower rate of readmission than the entire intervention group and an 8% 
stronger first appointment adherence compared to those participants who had a less than 
80% phone intervention compliance.  Baseline quality of life indicators were higher for 
the treatment as usual group in all domains except physical.  The post mean quality of life 
scores for the intervention group were lower in all categories compared to the treatment 
as usual group. 
 Conclusions:  The APRN Bridge Model may be a feasible consideration for this 
patient population but will require a new intervention than telephone communication.  
The intervention participants had more medical co-morbidities and lower quality of life 
than the treatment as usual group and this may have impacted readmission need and 
status.  Considerations to broaden the “bridge” protocol and improve cost effectiveness 
may include the addition of a Nurse Navigator role to manage the day to day safety 
follow up, utilization of a licensed independent social worker to manage social needs and 
the inclusion of the APRN to coordinate medication management and chronic medical 
needs assessment.   
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 Chapter 1: Introduction 
 
 
 The ability of psychiatric patients to comply with a post-inpatient discharge plan 
is a widespread community and public health issue (Viggiano, Pincus, & Crystal, 2012). 
Nationally, less than 42% of initial appointments following psychiatric hospitalization are 
kept (Batscha, McDevitt, Weiden, & Dancy, 2011).  Of the patients who miss their 
mental health outpatient appointments, 25%-to- 50% disengage from treatment 
completely (Killaspy, 2007).  Furthermore, the highest suicide risk for the mental health 
patients is the crucial post-inpatient discharge phase (Crawford, 2004).  Failure to secure 
the resources necessary for a successful transition between inpatient and outpatient care 
increases the likelihood of re-hospitalization or emergency level services (Batscha et al., 
2011).  These statistics are important, as it has been found that noncompliance with 
treatment after a psychiatric hospitalization increases the likelihood of re-hospitalization 
from one in 10 to one in 4 (Mitchell & Selmes, 2007).  Considering that costs for an 
inpatient stay can exceed $1,500 per day (Batscha et al., 2011) and the fact that the 
Centers for Medicare and Medicaid Services are tracking all- condition 30-day 
readmission rates, there is an organizational imperative to prevent readmissions in this 
patient population.  The Patient Protection and Affordable Care Act have given the 
Centers for Medicare and Medicaid Services the authority to penalize hospitals for 
excessive readmission rates related to certain conditions.  Currently, these conditions are 
primarily related to medical diagnoses, such as congestive heart failure.  However, 
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certain states are beginning to measure behavioral health readmissions under Medicaid 
(Mark, 2012).  Proactive recognition of factors that are associated with behavioral health 
readmissions may improve quality and outcomes (Mark, 2012). 
 In addition to the complexity of identifying and treating a mental health diagnosis, 
providers also have the challenge of treating both the mental health needs and complex 
chronic medical conditions of this client population.  Adults with severe psychiatric 
disorders have been found to have excessive medical morbidity and mortality as 
compared to the general population.  “This population dies on average 25 years sooner 
than others, often due to preventable medical illnesses” (Solomon, Hanrahan, Hurford, 
DeCesaris, & Josey, 2014, p. 1).  Utilization of providers who have expertise in mental 
health issues and the awareness to track and monitor medical complexities allows the 
Psychiatric Advanced Practice Registered Nurse (APRN) a distinct advantage to evaluate 
and follow patients that require a bridge in care from inpatient to outpatient versus the 
use of a social worker or licensed counselor.  Identifying innovative opportunities to 
improve treatment adherence, enhance client quality of life, prevent readmission and 
decrease overall costs can have a major impact on the overall transition plan for this 
patient population.  Therefore, the aim of this study was to test the feasibility, 
acceptability and preliminary effects of using a psychiatric APRN to bridge the gap 
between inpatient and outpatient care and improve outcomes in this high risk population. 
 Care transitions can be defined as “the movement patients make between health 
care practitioners and settings as their conditions and care needs change during the course 
of a chronic or acute illness” (Center For Improving Value in Health Care, 2012, p. 1).  It 
is often unclear during this time of transition which provider is responsible for the patient 
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in the period between discharge at one location and admission to another.  “This period of 
uncertainty has been called the “white space” and the “no care zone” (Center For 
Improving Value in Health Care, 2012, p. 2).  “Lack of a single health care “point 
person” can jeopardize successful transitions from the hospital to the community 
settings” (Batscha et al., 2011, p. 331).  Individuals diagnosed with a severe mental 
illness (SMI) are at risk of experiencing a vulnerable and unpredictable course during any 
transition of care.  Access to care for the SMI population may be a significant barrier 
because limitations on third party coverage, shortage of mental health professionals and 
lengthy wait times for appointments place clients at high risk for appointment and 
treatment non-adherence (Schaumberg, Narayan, & Wright, 2013).  Non-adherence to 
medications and the treatment plan is associated with re-hospitalization and suicide, 
worsening of symptoms, psychosocial deterioration, increased costs, relapse and poor 
quality of life (Rose, Gerson, & Carbo, 2007). 
 Quality of life is defined by the World Health Organization as “an individual’s 
perception of their position in life in the context of the culture and value systems in which 
they live, and in relation to their goals, expectations, standards and concerns” 
(Skevington, Lotfy, & O’Connell, 2004, p. 299).  Factors that may affect health related 
quality of life are occupation/employment, personal safety, mood, and quality of social 
relationships (Rose et al., 2007).  Patients with a diagnosis of SMI tend to report poorer 
overall quality of life that includes dissatisfaction with physical well-being, strained 
family relationships, disproportionately higher rates of disability and mortality, 
homelessness and inappropriate incarceration.  “Persons with major depression and 
schizophrenia have a 40% to 60% greater chance of dying prematurely than the general 
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population” (Sixty-Sixth World Health Assembly, 2013, p. 4).  Behavioral health 
conditions hinder work productivity, increase absenteeism, and can lead to reduced 
income or unemployment.  In 2007, persons diagnosed with a SMI had annual earnings 
averaging $16,000 less than the general population (Hogg Foundation for Mental 
Health/Methodist Healthcare Ministries, 2011).  These social impacts, in conjunction 
with treatment costs, present a significant and growing economic burden that has made 
mental illness one of the five most costly conditions nationwide (Agency for Healthcare 
Research and Quality, 2009). 
 The quality of life issues that the diagnosed SMI population lives with are 
significant to the person, the family unit and the population at large.  Stigma associated 
with this disease process can contribute significantly to the individual’s willingness to 
participate in care.  Even if the individual was receptive to inpatient care, as many as 70 
percent of suicide attempts by individuals of all ages never attend their first outpatient 
appointment (Knesper, 2010).  Elevated post-discharge rates of death by suicide, suicide 
attempts, and readmissions to acute care services have been repeatedly documented, but 
this has not been matched by proportionate prevention efforts.  In fact, the only two 
randomized controlled trials in the suicide prevention literature that have shown a 
reduction in the number of deaths by suicide have both involved following up with high- 
risk populations after discharge from acute care services (Knesper, 2010).  Explanations 
for suicides after hospitalization include re-exposure to community stressors, non-
adherence to established treatment plan, and non-engagement with outpatient providers, 
relapse, and the return of insight regarding the consequences of the mental illness.  “At 
discharge, the protective factors the hospital offers, including around the clock structure, 
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supervision, caring and support are abruptly lost” (Salvatore, 2012, p. 1).  “Bridging” 
strategies that reduce the break between inpatient and outpatient facilities and involve 
interpersonal communication, provider to client connection and motivational 
interviewing shows promise for gaining treatment plan adherence from inpatients with 
mental illness (Knesper, 2010).  The continuity of relationship building between inpatient 
and outpatient care is a dynamic influence that the Psychiatric APRN can impact. 
 APRNs are uniquely qualified to coordinate increasingly complex patient care and 
improve communication between health providers to prevent fragmentation of care 
(Robinson, 2010).  Despite the growing interest in the role of the APRN with transitional 
care, the literature pertaining to this role, specific to psychiatric/mental health nursing, 
has not been effectively studied.  The current body of literature on the APRN 
predominantly refers to primary health care (Wortans, Happell, & Johnstone, 2006). 
 Role of Theory to Guide Intervention 
 Theory provides the building blocks for an understanding of a practice, a 
phenomenon or a problem and guiding the explanation for how and why it occurs.  
“Theory reflects a body of knowledge that organizes, describes, predicts and explains a 
phenomenon and guides the planning for an interventional study” (Fleury & Sidani, 2012, 
p. 11).  With an interest in mental health access, quality of care and the process of 
effective transitions in continuity of care for this patient population, the search for a 
relevant theoretical model led to the middle range theory of Meleis Transition Theory.  
This middle range theory foundation rests in the disciplines of anthropology and 
psychology and has been used in various nursing studies to examine the vulnerable 
period of transitioning patients from one level of care to the next level of care (Meleis et 
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al., 2000).  Literature reviews of the model showcase its use in nursing practice including 
geriatric, psychiatric, medical surgical and maternal populations (Im, 2011).   
 Description of Theory 
 Meleis defined transition as “a passage, or movement, from one life phase, 
condition, or status to another, and the process and experience of undergoing a transition 
can result in a changed perception of health, new meaning, and a sense of control” 
(Skarsater & Willman, 2006, p. 246).  Continuity of care for mental health patients 
transitioning from inpatient to outpatient care is the primary focus of effective 
management and enhancing quality of life for this patient population (Viggiano et al., 
2012). 
The theoretical assertions of the model begin with examining the nature of the 
transition that the individual is facing in his or her life.  The nature of the transition can 
be based on the type of transition (developmental, situational, health/illness or 
organizational), the pattern of the transition (single, multiple, sequential, simultaneous, 
related or unrelated) and the properties associated with the transition (awareness, 
engagement, change and difference, time span and critical points and events).  As the 
nature of the transition is determined, personal and environmental conditions may 
facilitate or hinder progress toward achieving a healthy transition period.  At this point in 
the model is where nursing therapeutic interventions can assist in the pattern of response 
of the individual.  Patterns of response include process and outcome indicators that focus 
on the individual’s ability to feel connected, interact, develop confidence and coping 
skills effectively.  Outcome indicators primarily focus on mastery and fluid integrative 
identities that showcase the individual’s ability to adopt a new skill or coping mechanism 
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that will sustain recovery and allow a fluid process of learning in new situations 
(Skarsater & Willman, 2006).  A newly diagnosed mental health patient who has been 
hospitalized for the first time may have a very different transition period in comparison to 
the chronically mentally ill patient who has been hospitalized multiple times in his or her 
life.  The associated social issues related to the illness may impact the individual’s ability 
to maintain effective relationships, secure employment and maintain adult independence.  
The uniqueness and complexity of this patient population contributes to the type, pattern 
and properties, facilitators/inhibitors and patterns of response during this transitional 
phase.  The role of the APRN can foster effective nursing therapeutics to guide and 
support the individual through this period of vulnerability and transition. 
 Meleis Transition Theory supports several major constructs and concepts in its 
theoretical framework.  “Constructs are the theoretical and more abstract focus of the 
framework and concepts are focused more on the population of interest, the specific 
problem area or the area of structure and focus” (McQuiston & Campbell, 1996, p. 117).  
The overall constructs to this theoretical framework is the phenomenon of “vulnerability” 
and “transition.”  Vulnerability may be conceptualized as “a quality of daily lives 
uncovered through an understanding of client’s experiences and responses during times 
of transition” (Meleis et al., 2000, p. 12).  Therefore, vulnerability can relate to transition 
through the experience, interactions and environmental conditions that expose individuals 
to potential harm, problematic or extended recovery, or delayed or unhealthy coping.  
Individual’s daily lives, environments and interactions are shaped by the nature, 
conditions, meanings and processes of transition experiences.  “Transitions are therefore 
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both a result of and result in change in lives, health, relationships and environments” 
(Meleis et al., 2000, p. 12).  
Meleis et al. (2000) defined the goal of healthy transitions as “consisting of the 
mastery of behaviors, sentiments, cues, and symbols associated with new roles and 
identities and non-problematic processes” (Im, 2011, p. 282).  The concepts that are 
related to the Meleis Transition Theory are: (a) Nature of Transitions, (b) Transition 
Conditions: Facilitators and Inhibitors, (c) Patterns of Response and (d) Nursing 
Therapeutics (Im, 2011).  Each major concept has several related sub-concepts as well.  
The nature of the transitions includes types, patterns and properties.  Transition 
conditions include personal, community and societal.  The patterns of response include 
process indicators and outcome indicators.  With each of these sub-concepts additional 
related concepts emerge to more structurally define the categories (Im, 2011).  
 Proposed Theoretical Model 
 Much of the Meleis Transition Model encompasses the theoretical model of this 
pilot study.  However, a limitation to this theoretical framework with the psychiatric 
population is the potential exclusion of mediators and moderators which fail to account 
for the impact of these variables on the transitional experience.  In relation to this pilot 
study, the nature of the transition focus is on the health/illness of a psychiatric diagnosis 
that will progress the client from an inpatient psychiatric stay to an outpatient transition 
of care.  Various moderators may impact this transition, including severity of illness, 
psychiatric medications, and length of inpatient stay, age and substance abuse.  The 
nursing therapeutic (intervention) to assist with transitioning the client from the inpatient 
to outpatient continuum of care was the Psychiatric APRN Bridge Program and the 
9 
protocol associated with this intervention.  A distinct mediator in this model could be 
related to the therapeutic alliance that may or may not occur between the APRN and 
client.  The relationship and degree of the relationship that is built between the client and 
the APRN may have an effect on whether the intervention is successful.  Outcomes for 
the study are: (a) first outpatient appointment adherence, (b) 30-day readmission status, 
(c) direct and indirect hospital costs related to readmission status and (d) quality of life.  
The referential tools that were used to measure the outcome indicators are: (a) Medical 
record review that denotes first appointment adherence and readmission status, (b) 
Incremental Cost Effectiveness Ratio to evaluate direct and indirect costs, (c) The World 
Health Organization Quality of Life Scale-BREF, (d) Client self-report of first 
appointment adherence and readmission status, and (e) The Revised Helping Alliance 
Questionnaire.  The conceptual model that depicts the proposed pathway is introduced in 
Figure 1 and is adapted from the Meleis Transition Model. 
 Specific Aims and Research Questions 
 The primary purpose of this pilot study was to fill a gap in science as rigorously 
designed randomized controlled trials and evidence-based interventions are lacking to 
improve psychiatric transitional patient care.  This pilot intervention study determined the 
preliminary effects of using a psychiatric APRN to transition a patient from hospital to 
home on first outpatient appointment adherence, 30-day readmission rates, direct and 
indirect hospital costs related to readmission status and client quality of life.  Based on 
this general overview and theoretical modeling, the research questions of interest were: 
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Figure 1.  Conceptual Transitional Model.  Adapted from “Experiencing Transitions: An 
Emerging Middle Range Theory,” by A. Meleis, L. M. Sawyer, E. Im, E., M. Hilfinger, 
K. DeAnne, and K. Schumacher, 2000, Advances in Nursing Science, 23(1), 12-28. 
Copyright 2000 by Wolters Kluwer Health, Inc.  Fair Use Analysis completed and 
appropriate for adaptation. 
 
 
 1.  What is the feasibility and acceptability of using a Psychiatric APRN bridge 
program with psychiatric patients being discharged from the inpatient psychiatric hospital 
until first outpatient appointment? 
 2.  What are the preliminary effects of a Psychiatric APRN bridge program that 
links adult patients being discharged from a psychiatric inpatient unit to psychiatric 
outpatient services on: (a) first outpatient appointment adherence, (b) psychiatric hospital 
readmission within 30 days, (c) direct and indirect health care costs related to 
readmission status, and (d) clients’ quality of life?  
11 
 This pilot study tested the feasibility, acceptability and preliminary effects of 
using a psychiatric APRN to bridge the gap between inpatient and outpatient care and 
improve outcomes in this high risk population.  Pilot intervention studies and full-scale 
randomized trials are urgently needed in psychiatric nursing literature to advance the 
nursing intervention platform, provide an extension of the role of the APRN, and improve 
patient outcomes.   
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 Chapter 2: Review of Literature 
 
 
 The current body of literature on the role of the APRN with “bridging” care for 
clients transitioning from inpatient to outpatient care has largely been studied in the 
primary chronic health care venues.  To understand the outcomes and potential benefits 
of this role in psychiatric care, it is necessary to examine the literature of the APRN role 
in a broader general health care approach.  Transitional care models for chronic health 
conditions have been utilized by various care transition experts, such as: Dr. Eric 
Coleman, the Care Transitions Model; Dr. Mary Naylor, Transitional Care Model; Dr. 
Brian Jack, Project RED; and Dr. Dorothy Brooten, The Quality Cost Model of the APN 
Transitional Care (Center For Improving Value in Health Care, 2012).  To date, Naylor 
and colleagues have completed three multi-site NINR-funded randomized clinical trials 
which consistently demonstrated the effectiveness of the APRN in assisting with 
transitional planning and improving post-discharge health outcomes in older, chronically 
ill adults, including physical function, quality of life and safety.  The same studies have 
also shown a 20% reduction in re-hospitalization rates (Robinson, 2010).  Recently, 
colleagues of Dr. Mary Naylor adapted her evidence-based transitional care model for 
older adults and evaluated transitional care for patients with a diagnosis of serious mental 
illness and medical co-morbidities that were discharged from two psychiatric units 
(Solomon et al., 2014).  The transitional care model utilized a psychiatric Nurse 
Practitioner in evaluating the facilitators and barriers to a 90-day transitional care 
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intervention pilot study.  The intervention used in this model was a combination of the 
APRN visiting with the patient pre-inpatient discharge and evaluating the patient in their 
home post-discharge.  The APRN also went with the patient to primary care 
appointments and was available via phone 7 days per week.  Case narratives by the 
APRN of 20 intervention participants were content analyzed.  Responses to the pilot 
study show that individuals with pressing physical needs were most receptive to the 
transition intervention, however, those with strictly psychosocial needs may best benefit 
from a team approach that utilizes social workers, licensed counselors and others to most 
efficiently and cost effectively assist in a successful transition (Solomon et al., 2014). 
 Many of the mechanisms of care that are highlighted in the literature have further 
opportunities for testing with the SMI population.  Dr. Eric Coleman has been 
instrumental in developing The Care Transitions Program that utilizes APRNs as 
“transition coaches” to maximize quality and safety during a care transition period.  The 
focus is on medication management and timely follow-up of worsening client conditions.  
This model utilizes the transition coach to visit the patient prior to inpatient discharge and 
a one-time home visit 2-3 days post-discharge.  The strengths of the program showcase a 
30% lower readmission rate and an average cost savings of $488 per patient.  Limitations 
of the program do not allow the transition coach to follow the patient extensively and the 
model lacks evidence with the psychiatric patient population (Center For Improving 
Value in Health Care, 2012). 
 Intervention studies specific to the transition of care for psychiatric patients have 
been limited and relied more on qualitative approaches versus randomized controlled 
trials.  A review of published intervention studies in five psychiatric nursing journals 
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evaluated from 2006-2010 revealed that “55% of the studies had no randomization or use 
of a control group and only one study was labeled by its author as a randomized, 
controlled trial” (Zauszniewski, Bekhet, & Haberlein, 2012, p. 7).  A more recent review 
that evaluated a 21-year time frame between 1990 and 2011 in two key nursing databases 
(CINAHL and PSYCHINFO) identified only 19 peer reviewed literature manuscripts that 
discussed the discharge process outcome needs of the psychiatric client from inpatient to 
outpatient (Nurjannah, Mills, Usher, & Park, 2013).  Results of this integrative review 
continue to highlight the limited amount of research findings related to the discharge 
planning process and the impacts on aftercare compliance in this population.  The 19 
articles highlighted that communication is the most important aspect of the discharge 
planning process and aftercare compliance, health status and readmission rates are 
common variables used to measure the impact of discharge planning on the well-being of 
individuals living with a mental illness (Nurjannah et al., 2013).  Only one of the 
manuscripts reported the importance of effective communication between the consumer 
and a Nurse Practitioner (Wortans, as cited in Nurjannah et al., 2013).  This review 
reinforced the fact that there is currently no gold standard for effective discharge 
planning and highlighted the need for further research studies to identify factors that 
contribute to an effective transition of care.  As a result, “this analysis continues to 
showcase the limited scientific support for many psychiatric nursing interventions” 
(Zauszniewski et al., 2012, p. 9).  The literature review and psychiatric interventional 
studies that have been published to date are limited and lack high level evidence in much 
of this field.  A summary of the relevant psychiatric transitional studies for review is 
found in Appendix A. 
15 
Extending the Science with this Pilot Study 
 The ability to answer the presented research questions in a pilot study will assist 
in advancing the science of the role of the Psychiatric APRN in transition planning and 
health outcomes for a high risk population of patients.  The literature review and 
psychiatric interventional studies that have been published to date are limited and lack 
high level evidence in much of this field.  Much has been published and studied related to 
the role of the APRN on managing chronic medical conditions.  The expertise associated 
with an APRN’s specialized skills and knowledge base allows for enhanced transition of 
care and bridging the gap in care between service settings.  Pilot intervention studies and 
randomized controlled trials are needed in psychiatric nursing literature to advance the 
nursing intervention platform and provide an extension of the role of the APRN that will 
be beneficial in future care models.  This particular research question and the specific 
aims associated with the question are the basis for this pilot study to test the feasibility 
and acceptability of utilizing a psychiatric APRN to bridge the gap between inpatient and 
outpatient care.  A pilot study is a required initial step in exploring an intervention or an 
innovative application of an intervention.  “Pilot results can inform feasibility and 
identify modifications needed in the design of a larger, hypothesis testing study” (Leon, 
Davis, & Kreamer, 2011, p. 626).  The mental health care system and the complexities of 
funding and community support are requiring organizations to look for a more efficient 
model of care.  The use of APRNs’ to bridge care delivery has the potential to improve 
treatment adherence, quality of life, reduce hospital readmissions and demonstrate cost 
effectiveness.  Adopting a theoretical framework that is focused on transitional care will 
guide and direct the initiatives of a new innovative model for mental health care. 
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 Chapter 3: Methodology 
 
 
 Study Aims 
 
 The purpose of conducting a pilot study is to examine the feasibility of an 
interventional approach that is intended to be used in a future larger scale study to 
determine full scale efficacy.  “A pilot study can be used to evaluate the feasibility and 
applicability of recruitment, randomization, retention, assessment procedures, new 
methods and implementation of a novel intervention” (Leon et al., 2011, p. 1).  The goal 
of the pilot study is to also assess if the proposed intervention makes a difference in 
outcomes.  “This is often quantified as effect size and provides data needed to determine 
sample size in the full scale study” (Melnyk, Morrison-Beedy,  2012, p. 54). 
 The primary aims of this pilot study were to:  
 1.  Examine the feasibility and acceptability of using a Psychiatric APRN Bridge 
Program with psychiatric patients being discharged from the inpatient psychiatric 
hospital. 
 2.  Evaluate the preliminary effects of the program on: (a) first outpatient 
appointment adherence, (b) 30-day psychiatric hospital readmission rate, (c) direct and 
indirect hospital costs related to readmission and (d) client quality of life. 
 3.  To determine relationships among the identified study variables as a first step 
in testing potential mediators and moderators. 
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 Study Design 
 The design used a two group randomized controlled pilot study to assess the 
preliminary effects of the psychiatric APRN Bridge Program intervention on key 
outcomes for psychiatric patients.  The graphical exhibit of this design is based on the 
Campbell and Stanley, 1963 representation (Melnyk et al., 2012). 
 R   O1   X1   O2 
 
 R   O1   X2   O2 
 
R = random assignment, O1 = baseline demographics and measures, X1= 
intervention group, X2 = treatment as usual, and O2 = post intervention observation. 
    Participants 
 Participants for this study were recruited while an inpatient on one of two adult 
psychiatric units.  The focus of recruitment was patients with a DSM-5 diagnosis of 
bipolar or major depressive disorder on admission to the inpatient unit.  After the 
capacity assessment and consent process for participation occurred, the participants were 
randomized to either the intervention group (Bridge Protocol) or the treatment as usual 
control group (usual discharge planning) by random numbers assignment.  Fifty numbers 
were generated to coincide with 25 being random intervention assignments and 25 being 
random treatment as usual assignments. Fifty two participants were approached about 
participation in the study while an inpatient on the adult psychiatric unit.  Two potential 
participants declined enrollment, one participant was identified post consent as ineligible 
and one participant withdrew consent.  Forty eight participants were actively enrolled in 
the study.  Twenty three participants were randomized to the treatment as usual group 
and twenty five participants were randomized to the intervention group. Recruitment 
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flyers were posted on the inpatient units and the PI would be called by the patient or unit 
staff if a patient was interested in discussing the study.  The PI would make daily rounds 
on the units to consent patients to the study.  Participants had the ability to enroll in the 
study if they met the inclusion requirements and any issues with capacity were evaluated 
by their attending physician with the research team prior to recruitment and consent.  
Every effort was made to retain participants within this study period.  A modest retention 
incentive ($10 gift card to a grocery store) was offered to all participants that enrolled in 
the 30-day study.   
 Setting and Sampling Methodology 
 The setting for this proposed pilot study was an inpatient psychiatric facility at an 
academic medical center in the Midwestern United States.  The facility included two 
adult psychiatric units and clinic space in the hospital building.  This inpatient psychiatric 
setting has approximately 225 adult admissions per month and an average length of stay 
of 7 days.  Approximately 60% of the adult population admitted to these adult inpatient 
units has a diagnosis of bipolar disease or major depressive disorder.  The 30-day 
readmission rate for this patient population at this setting is approximately 10%.  
Outpatient follow-up can range from 1 week to 3 months.  The sample of patients for this 
study had the following inclusion criteria: (a) English speaking adult psychiatric 
inpatients that are 18-65 years old, (b) admission DSM-5 diagnosis of bipolar disorder or 
major depression, (c) has not actively attempted suicide  prior to admission, (d) deemed 
by attending physician as having the capacity to ethically participate in a research study, 
and (e) will require outpatient follow-up care through the named academic medical center 
provider resources upon discharge from the inpatient psychiatric unit.   
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Convenience sampling was the sampling methodology used for this study.  
Sample size was based on pragmatics of recruitment with a goal of 50 participants (25 
per group). The setting for data collection included the inpatient psychiatric unit, 
telephone and clinic space at the hospital setting. 
Ethical Principles 
 Although convenience sampling offers many advantages to the research 
recruitment process, many considerations must be evaluated in this vulnerable human 
subject population.  The Belmont Report: Ethical Principles and Guidelines for Research 
Involving Human Subjects identified the three basic principles that must be considered in 
all evaluations of human actions: the principles of respect of persons, beneficence, and 
justice (C. Coleman, Menikoff, Goldner, & Dubler, 2005).  Respect for persons identifies 
that individuals should be treated as autonomous agents and that persons with diminished 
autonomy, such as with a mental disability, are entitled to protection.  The principle of 
beneficence ensures that the study is obligated to doing no harm and maximizing possible 
benefits and minimizing harm.  Lastly, justice speaks to being fair in what is deserved 
and not exploiting unwilling or un-knowledgeable participants for the sake of research 
(Coleman et al., 2005).  Informed Consent and IRB review have served as the primary 
safeguards in human research in the United States (Coleman et al., 2005).  “However, 
individuals with mental disorders may lack the general health care knowledge or the 
ability to understand their rights and thus the process for consent may need to be 
modified to provide a “goodness of fit” between the person and the general aspects of the 
consent” (Coleman et al., 2005, p. 347).  Opportunities to alter the language level, and 
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modify the consent setting process to reduce power inequities may assist in this goodness 
of fit option. 
 Mental illness is an area of vulnerability to research practice and informed 
consent due to the variety of ways that the disease process can impact capacity and the 
proposed research guidelines impacting the disease process. Capacity for exercising 
autonomous decisions can be variable based on the illness impacting the patient at the 
time of consent.  “Incapacity can occur once, intermittently or continually in an adult 
person’s life” (Dresser, 1996, p. 67).  It is therefore imperative to not only rely on an 
informed consent document or IRB approval but to consider other ethical requirements 
for making a systematic decision on ethical participation in research involving this 
population.  “Seven ethical requirements for systematically evaluating the ethics of 
clinical research studies have been identified and recommended to clinical researchers” 
(Emanuel, Wendler, & Grady, 2000, p. 2701).  The seven requirements are: (a) does the 
study add value-enhancements in the health and knowledge of the population, (b) is there 
scientific rigor and validity to the study, (c) fair subject selection, (d) favorable risk-
benefit ratio, (e) independent review, (f) informed consent and (g) respect for enrolled 
subjects--privacy protected, opportunity to withdraw and their well-being monitored 
(Emanuel et al., 2000).  In relation to the pilot study, the requirements for ethical 
monitoring were maintained.  The study brings value to the mental health psychiatric 
population by utilizing a bridge model for this population that primarily has only been 
scientifically reviewed in the chronic medical population.  Evidence-based results have 
shown improvement in functional capabilities and the reduced need for re-hospitalization 
in these published medical studies.  The study has an experimental, randomized design 
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and relies on scientific validity to further this pilot study to a larger scale study.   The 
pilot study had no defined health risks because even the treatment as usual group received 
the same level of care as they are currently receiving.  The benefits that were 
hypothesized for the intervention group were to see if additional support would aid this 
population of patients.  Much of the risk associated with mental health research is tied to 
two distinct studies: (a) Challenge studies--researchers intentionally give patients 
pharmacological agents in order to induce and study psychiatric symptomatology and (b) 
Washout studies--patients are removed from all psychiatric medication to study baseline 
status or pure effects of new drug treatments.  Neither one of these areas were evaluated 
in this pilot study.  IRB approval was received from The Ohio State University 
Institutional Review Board and a consent process was established in writing to allow 
voluntary consent and knowledge regarding the study.  The five main components of 
informed consent were maintained: (a) potential participants were competent, alert and 
oriented; (b) a reasonable amount of information should be provided regarding the study 
goals, design, risks, benefits, alternatives, expectations on subjects and their rights; (c) 
opportunity for subjects to ask questions; (d) coercion and manipulation should be 
avoided; and (e) authorization should be obtained and documented, using the most 
appropriate method for the subjects (Mathuna, 2012).  Participants were protected 
throughout the study and well monitored during the 30-day protocol.  Participants had 
access to emergency care at any time. 
 Currently, the United States has no specific policy on research involving persons 
with mental disabilities.  The Belmont Report is a useful starting point for evaluating the 
needs of this population.  Federal law has assigned the responsibility to institutional 
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review boards for determining whether protective measures are appropriately in place 
(Dresser, 1996).  It is therefore the Principal Investigator’s role to ensure that participants 
can expect the trust and respect of the research team throughout the study, recognizing 
that consent is a process, not just a signed document.  Another recognized resource for 
ensuring ethical conduct and needs of the individual participants is incorporating an 
individual otherwise unaffiliated with the project (Dresser, 1996).  This pilot study 
utilized the organization’s Patient Rights Advocate to assist with any individual questions 
or participant needs throughout the study.  The initiatives planned for this pilot study 
ethically supported the needs of the participants. 
     Research Protocol 
 The Psychiatric APRN Bridge Program evaluated the effects of the intervention 
group against the treatment as usual group.  The research protocol is highlighted in 
Figure 2. 
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Psychiatric Advanced Practice Registered Nurse Bridge Program Protocol 
 
Protocol: 
Treatment as usual Intervention (Nursing Therapeutic) 
1.  Pre-Discharge:  Principal Investigator (PI) 
consented participants for study.  Once consented, the 
PI randomly assigned participants to treatment as usual 
or intervention group and assigned a participant code 
number. 
 2.  Within 48 hours of discharge:  current discharge 
planning. 
1.  Same 
2. Within 48 hours of discharge:  APRN introduced 
themselves to the patient and support individuals and 
provided information on the protocol and APRN contact 
information.  APRN validated contact number of the 
participant. 
3.  Within 24 hours of discharge:  Research Assistant 
collected and administered (a) demographics from 
patient and EMR, (b) The World Health Organization 
Quality of Life Tool-BREF. 
4.  Research Assistant communicated that follow-up 
call will occur at day 31 of study to collect information. 
3.   Same plus:  APRN connected with the patient and 
support individuals to re-validate discharge information 
and plan for 24 hour post discharge phone call and 
weekly phone contact during the inpatient to outpatient 
transition. 
4.   Research assistant communicated that follow-up 
call will occur at day 31 of study to collect follow-up 
information. 
5.  At Discharge:  Inpatient treatment team provided:  
(a) discharge instructions, (b) prescriptions and 
medication review, (c) outpatient linkage appointment, 
and (d) review of safety and housing plan. 
5.  Same 
 6.  24 hours post discharge:  APRN contacted client 
via phone to provide a safety check:  (a) how are you 
feeling? (b) Did you get your prescriptions filled and do 
you have any questions on your medications?  (c) 
Where are you staying (d) Share with me your safety 
plan and contact numbers if you would need immediate 
assistance (e) Established plan to provide weekly 
phone call connection checks 30 days post discharge. 
 7.  Weekly:  APRN hosted a weekly phone call 
connection with each client for 30 days to evaluate 
outpatient appointment adherence, medication 
compliance, safety plan needs and supportive 
motivational interviewing questions to enhance intrinsic 
motivation and client engagement.  A phone call log 
was established to document calls attempted to actual 
calls completed. 
8.  At day 7, a post card was mailed to the clients from 
the APRN/PI providing a connection, support and on-
going motivation for a successful transition. 
6.  At 31 days post discharge:  Research Assistant 
collected information via phone call:  (a) The World 
Health Organization Quality of Life Tool-BREF, (b) 
follow-up questions--Did you attend your first outpatient 
appointment as scheduled and did you require a 
psychiatric re-hospitalization in the past 30 days?  After 
data was collected from participants, the research 
assistant validated the self-report information with 
medical record validation of attendance to outpatient 
provider appointment and readmissions to same 
psychiatric hospital. 
7.  Data Management:  Data entered into SPSS 
database by research assistant and PI performed 
100% validation of data entered. 
9.  Same information collected at 31 day post discharge 
plus:  Therapeutic Alliance Survey  
 
 
 
 
 
 
10.  Data Management: Same 
8.  Analysis of AIMS:  PI and Statistical consultant 
evaluated data and determined feasibility and 
acceptability of model. 
11.  Analysis of AIMS: Same 
 
Figure 2.  APRN Bridge Program Protocol. 
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 Measures and Instruments 
 The basic premise of research measurement “focuses on ensuring that you are 
measuring the outcome metric that is most important to measure and whether there is 
consistency in measurement” (Melnyk & Morrison-Beedy, 2012, p. 123).  During this 
phase of the research pilot study, focus is on “testing the tests” versus “testing the 
participants” (Begun, 2012).  It is critical that instruments are valid and reliable.  The 
assessment of validity and reliability with all measurement tools is the psychometric 
principle for sound measurement.  “Validity is defined as gathering evidence to conclude 
that your measure actually taps the construct you intend to measure.  Reliability is 
defined as the ability of an instrument to consistently measure what it claims to measure” 
(Melnyk & Morrison-Beedy, 2012, p. 124).  Criteria for measuring validity was 
completed by evaluating content, criterion related and construct principles.  Content 
validity can be measured by utilizing experts in the field to confirm that the measure is 
measuring what it is supposed to measure.  A second approach is to use the “users” of the 
construct of interest to provide feedback on whether the items are actually measuring the 
appropriate components based on their experience.  A content validity index is the 
common assessment approach for these indices.  Criterion related validity is established 
by comparing the measure to what is considered the “gold standard.”  This comparison 
can be done at one time (concurrent) or at two different times (predictive).  Pearson 
correlation coefficient (r) is the common assessment approach for these indices.  Lastly, 
construct validity assesses how well the measure meets the theoretical expectations of 
your construct of interest.  If positively correlated this would provide evidence for 
convergent validity.  If negatively correlated, this would provide evidence for divergent 
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validity.  Exploratory and confirmatory factor analyses are the common approaches for 
assessment of these indices (Melnyk & Morrison-Beedy, 2012). 
 Criteria for measuring reliability was completed by internal consistency, test-
retest and inter- and intra- rater reliability.  Internal consistency describes how items 
within a measure relate to each other and “hold together” as one construct.  The most 
common indices for this measurement are Cronbach’s alpha coefficient.  Higher scores 
on this coefficient indicate greater consistency between items. Minimally acceptable 
alpha is .7. Test-retest reliability focuses on the stability or consistency of a measure from 
one time to another.  The common indices for this metric of reliability are the Pearson 
correlation coefficient (r).  The final criteria metric for reliability is inter- and intra- rater 
reliability.  This measure can be assessed by comparing the scoring on instruments 
between at least two trained independent raters (inter-) and comparisons by the same rater 
over time (intra-).  The common indices for assessment approaches are the Kappa 
coefficient (Melnyk & Morrison-Beedy, 2012). 
 The measurement tools that were used in this pilot study are the following: 
 Self-Report and Medical Record Review.  The dependent variables for this study: 
first outpatient appointment attendance and hospital readmission within 30 days were 
obtained via self-report and medical record validation review.  These two variables were 
recorded as a binomial yes/no variable. 
 The World Health Organization Quality of Life Tool-BREF.  The quality of life 
instrument that was used in this pilot study was the World Health Organization Quality of 
Life Tool-BREF.  The tool has 26 Likert type scale questions and takes approximately 
five minutes to complete (McDowell, 2006).  Four domains are measured that include: 
26 
physical and psychological health, social relationships, and environment.  The literature 
highlights past studies that show Cronbach’s alpha reliability are .82 for physical health, 
.81 for psychological health, .80 for environment but marginal with social relationships at 
.68.  Discriminant validity was compared with sick and healthy populations.  
Discriminant validity was significant for each domain in the population tested and best 
demonstrated in the physical domain, followed by psychological, social and 
environmental domains (Skevington et al., 2004).  Future work remains on properties of 
validity and test-retest reliability with larger participant populations (Skevington et al., 
2004).  The QOL survey was administered to study participants 48 hours pre-inpatient 
discharge and at day 31.  After coding the data set, a raw score is computed by a simple 
algebraic sum of each item in each of the four domains.  Raw scores were then 
transformed using a dedicated associated formula.  Higher scores indicate higher quality 
of life.  Appendix B provides a copy of the Quality of Life Tool. 
 The Revised Helping Alliance Questionnaire--Patient and Therapist (APRN) 
Version.  A secondary Likert-type scale evaluation tool that was given to the participants 
of the intervention group only was the Revised Helping Alliance Questionnaire--Patient 
Version.  The APRNs also completed the Therapist Version of the Questionnaire (Martin, 
Garske, & Davis, 2000).  The purpose of completing these questionnaires was to gather 
information on the possible mediating influence of the APRN relationship for further 
study.  Evaluating the consistency between the participant and the APRN answers to the 
individual questions was evaluated for significance.  Cronbach’s alpha for this tool is .91 
(Martin et al., 2000).  Appendix C provides a copy of the Alliance Tool. 
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 Phone Call Tracking Log.  Measured call attempts to actual calls completed, 
intervention group only. 
 Procedure 
 The study was approved by the Institutional Review Board of The Ohio State 
University.  The Principal Investigator (PI), in collaboration with the academic mentoring 
committee, was responsible for the overall project design, IRB approval, implementation 
and management, statistical analysis, and dissemination of findings.  Appendix D 
provides copies of IRB related materials.  Recruitment for participants in the study and 
the consent process was completed at the unit level by the PI.  Recruitment was expected 
to require 4-6 months to reach the sample goal of 50 participants.  The PI was not a part 
of the patient treatment team and did not have any potential conflict of interest for the 
patient’s care during their inpatient stay.  The PI would meet confidentially with each 
potential participant and explain the study, ensure they were aware that their participation 
was voluntary and they could withdrawal at any time.  Individuals who agreed to 
participate in the study were consented by the PI.  In the case of questions related to 
individual capacity, the PI reviewed the case with the attending physician to ensure that 
the client was competent to participate. 
Once participants consented to the pilot study, the PI was responsible for 
assigning random numbers to the 50 participants to determine if they were in the 
treatment as usual group or the intervention group.  A unique study identification code 
was assigned to each participant and a research assistant was responsible for keeping the 
master list of the medical record numbers that are tied to the individual participant code 
numbers.  The research assistant then collected the baseline patient demographics for all 
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participants, emergency contact numbers, and administered the World Health 
Organization Quality of Life Tool-BREF to all participants within 48 hours of inpatient 
discharge.  Baseline demographics included: admission date, discharge date, age, sex, 
education, marital status, insurance, employment, race and ethnicity, and a generalized 
health history which included discharge diagnosis, number and type of discharge 
medications, and whether the participant had an established outpatient provider.  This 
information was collected via participant interviews and review of the electronic medical 
record. 
Intervention 
Four dedicated psychiatric APRNs and their collaborating physicians were 
assigned to follow the intervention participants in the study.  Once consent and pre-
discharge information were collected, introductions were made by the APRN to the 
patient and support individuals at 48 and 24 hours prior to discharge from the inpatient 
setting.  The purpose of these initial visits was to make an introduction, provide contact 
information for the APRN to the participant and support individuals, explain the protocol 
to the participant and role of the participant, and establish the schedule for telephone 
calls, and to validate a phone number for the initial 24 hour post-discharge safety check 
call.   
Standard Treatment as Usual:  All participants received the current standard 
treatment as usual discharge instructions that are given at the time of discharge by the 
staff RN, social worker, and physician.  The usual discharge planning included: (a) post-
discharge outpatient scheduled appointment, (b) prescription and medication review, and 
(c) review of the safety and housing plan for discharge.  The treatment team was blinded 
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to the group assignment.  Currently, there is no standard follow-up with patients once 
discharged from this facility.  Participants that are in the treatment as usual group 
received no further contact from the research team until day 31 for post-measurement 
follow-up.  
Intervention Group:   Individuals in the intervention group received a 24-hour 
safety check call by the APRN to assess for the following: (a) how are you feeling, (b) 
did you fill your prescriptions and do you have questions on your medications, (c) where 
are you staying, (d) share with me your safety plan and contact numbers if you would 
need immediate assistance, and (e) remind participant of first scheduled outpatient 
appointment and the next APRN phone call connection with the participant. The APRN 
then completed weekly phone calls to evaluate treatment adherence, medication 
compliance, safety plan needs and supportive motivational interviewing questions to 
enhance intrinsic motivation and client engagement.   
At day 31, the research assistant contacted the participants of the study to do 
follow-up surveys and evaluations.  The post-pilot information collected was: (a) 
WHOQOL Tool-BREF, (b) self-report and medical record validation of attendance to the 
first outpatient appointment, (c) self-report and medical record validation of psychiatric 
hospital readmission status within 30 days, (d) Therapeutic Alliance Survey--intervention 
participants only completed by the PI, and (e) Phone Call log--intervention participants 
only. 
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Fidelity of the Intervention 
 Accuracy and consistency with the implementation of this intervention is critical 
in maintaining the fidelity of the protocol.  Recognizing that the current treatment as 
usual is being done daily in the current setting, no additional fidelity protocol was needed 
for this arm of the study.  However, several mechanisms for ensuring fidelity of the 
protocol for the intervention group were utilized: (a) Development of a clear intervention 
protocol with prescribed scripting for the APRN, (b) Staff training to the  protocol for all 
participants and motivational interviewing training for APRNs involved in study, (c) PI 
review of protocol implementation with phone calls two times in the 30 days for each 
APRN, and (d) APRN documentation that included journal entries of each session and 
topics discussed in the electronic medical record.  Fidelity of the APRNs in delivering the 
protocol was assessed by direct observation and feedback from participants through the 
alliance survey by the PI.  The participants in the study were evaluated on their “receipt” 
of the intervention by the following mechanisms: (a) did they have an adequate safety 
plan and were medications available at the 24-hour post-discharge phone call, and (b) did 
they accept and participate in weekly phone calls?  
 Data Processing and Management 
 Preliminary data analysis began with review and double verification of data 
between the PI and the Research Assistant.  Variables were created in SPSS data base and 
descriptive frequencies were run for all variables to examine skewness, distribution, 
frequencies, percentages, means and standard deviations.  Sample size for the 
demographic baseline variables and dependent variables were less than 30 and 
predominantly nominal or ordinal measures, thus, nonparametric testing for correlation 
31 
was analyzed via Spearman rho correlation coefficient.  Data evaluation for this pilot 
study analyzed the following aims: 
 Analysis for Aim #1.  Feasibility and acceptability of using a Psychiatric 
Advanced Practice Nurse Bridge Program with psychiatric patients being discharged 
from the inpatient psychiatric hospital was conducted.  Few studies have assessed the role 
of the psychiatric APRN with transitional care planning and the outcomes associated with 
hospital readmission and outpatient treatment adherence.  Recognizing that the 
population is different than the well-studied chronic medical population; this pilot study 
goal was to estimate effect size for a larger full scale study in the future.  This study was 
considered acceptable if 80% of the intervention clients accepted and participated in the 
call schedule and remain in the 30-day intervention study.  Utilization of the phone call 
log in measuring contact attempts and contact successes provided a tool for measurement. 
 Analysis for Aim #2.  Preliminary effects of using a Psychiatric APRN Bridge 
Program with psychiatric patients being discharged from the inpatient psychiatric hospital 
on (a) first outpatient appointment adherence, (b) 30-day psychiatric hospital readmission 
rate, (c) direct and indirect hospital costs related to readmission, and (d) client quality of 
life were evaluated.  Descriptive statistics were conducted initially to describe the pilot 
sample based on the demographic variables that were collected at the beginning of the 
study.  Baseline demographics included: admission and discharge dates to calculate 
hospital length of stay, age, sex, education, marital status, insurance, employment, race 
and ethnicity, and a generalized health history to include discharge diagnosis, number and 
type of discharge medications and whether the participant has an established outpatient 
provider.   
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Calculation of effect sizes for each of the outcomes and inferential statistics were 
conducted.  Due to the small sample size, the statistical significance threshold was set at 
p<.10.  An independent t- test statistic was used to determine whether a difference existed 
between the intervention/control groups for quality of life.  Effect size indicators for the 
quality of life tool were based on comparison of standardized means of comparing the 
effect of a treatment on the mean scores of the two groups.  Logistic regression using 
maximum likelihood estimation was used to address the first appointment adherence and 
30-day readmission aim.  Length of stay, total medications at discharge, and discharge 
diagnosis were included as co-variates due to clinically meaningful differences between 
groups at baseline.  Race and marital status also were included as co-variates.  An 
incremental cost-effectiveness ratio (ICER) analysis was calculated to determine 
preliminary cost-effectiveness of the APRN bridge program.  The ICER numerator 
included the APRN salary costs and hospital office expenses.  The ICER denominator 
included readmissions averted and length of inpatient stay. 
 Analysis for Aim #3.  To determine relationships among the identified study 
variables as a first step in identifying potential mediators and moderators, Pearson chi 
square was computed. 
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 Chapter 4: Results 
 
 
 Study Demographics 
 
 The study sample socio-demographic characteristics of the participants are 
summarized in Table 1. 
  There were no statistically significant differences in the study demographics 
except for inpatient length of stay and medications at discharge between groups. 
Correlations among key variables were examined.  A total of 52 patients were 
approached and 48 were recruited into the study.   
 Analysis for Aim #1 
The feasibility and acceptability of utilizing an APRN Bridge program in 
psychiatric care was evaluated in this pilot study.  Feasibility of utilization of this 
intervention was considered from an institutional and patient perspective.  The inpatient 
setting, the availability to utilize current APRNs that were in the organization and the 
administrative support of the hospital allowed this intervention to be feasible and 
appropriate.  This researcher had immediate access to the electronic medical record of the 
participants that were involved in the study which allowed for follow-up and concurrent 
evaluation of fidelity of the intervention.  Research assistance was available from the 
organization which allowed for the timely survey follow-up and verification of all data 
entered into the data base.   There were consistent screening questions utilized by the 
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APRN with each phone call and answers to the weekly calls were documented in the 
electronic medical record for all parties on the research team to review per protocol. 
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Table 1 
 
Study Demographics 
 
Group 
Treatment as usual Intervention 
n = 23 n = 25 
Mean age (SD) 38.33 (17.692) 36.12 (12.551) 
   
Variables N (%) N (%) 
Sex 
     Male 
     Female 
 
12 (52.2%) 
11 (47.8%) 
 
12 (48.0%) 
13 (52.0%) 
Race 
     Caucasian 
     African-American 
     Asian 
     American Indian 
 
14 (60.9%) 
6 (26.1%) 
2 (8.7%) 
1 (4.3%) 
 
20 (80.0%) 
4 (16.0%) 
1 (4.0%) 
0 (0.0%) 
Ethnicity 
     Hispanic/Latino 
     Non-Hispanic/Latino 
 
0 (0.0%) 
23 (100.0%) 
 
0 (0.0%) 
25 (100.0%) 
Education Level 
     Some high school 
     High school 
     Some college 
     Associates degree 
     Bachelor’s degree 
     Master’s degree 
 
4 (17.0%) 
6 (26.0%) 
8 (35.0%) 
0 (0.0%) 
5 (22.0%) 
0 (0.0%) 
 
3 (12.0%) 
4 (16.0%) 
9 (36.0%) 
2 (8.0%) 
6 (24.0%) 
1 (4.0%) 
Marital Status 
     Single 
     Married 
     Separated 
     Divorced 
 
14 (60.9%) 
5 (21.7%) 
0 (0.0%) 
4 (17.4%) 
 
11 (44.0%) 
7 (28.0%) 
2 (8.0%) 
5 (20.0%) 
Employment 
     Employed 
     Not employed 
 
8 (34.8%) 
15 (65.2%) 
 
9 (36.0%) 
16 (64.0%) 
Insurance 
     Yes 
     No 
 
23 (100.0%) 
0 (0.0%) 
 
25 (100.0%) 
0 (0.0%) 
Discharge Diagnosis 
     Major depressive disorder 
     Bipolar 
 
14 (60.9%) 
9 (39.1%) 
 
20 (80.0%) 
5 (20.0%) 
Outpatient provider arranged 
     Yes 
     No 
 
20 (87.0%) 
3 (13.0%) 
 
24 (96.0%) 
1 (4.0%) 
Discharge meds 
     Yes 
     No 
 
23 (100.0%) 
0 (0.0%) 
 
25 (100.0%) 
0 (0.0%) 
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The adult psychiatric inpatient population was an eager group of individuals to 
recruit and consent for the study.  It was initially thought that recruitment would take 4-6 
months to complete for this pilot study.  The sample size was reached in 3 months and 
refusal to participate was low at only 2 of 52 (3.8%) potential patients refusing to 
participate.  Several of the participants stated that this type of intervention was a “no 
brainer” and support after discharge was “incredibly needed.”  Although there were a few 
successes of how the phone communication link improved treatment adherence, the 
phone call intervention was not the most feasible and successful plan for 
researcher/APRN to participant communication. Forty percent of the treatment as usual 
participants and 44% of the intervention participants failed to complete all aspects of the 
study.  This was an unexpected high attrition rate.   Table 2 showcases the attempts 
versus completion logs for the APRN interaction interventions of the study.  Table 3 
provides an APRN subgroup analysis of telephone dose intervention and impact on first 
appointment adherence and 30-day readmission rates. 
 
Table 2 
 
APRN Interaction Log 
 
Intervention 
Attempt 
percentage 
Complete 
percentage 
Participants visited personally in hospital prior 
   to discharge 
25 (100%) 25 (100.0%) 
24 hour safety call 25 (100%) 13 (52.2%) 
Week 1 Call 25 (100%) 11 (45.5%) 
Week 2 Call 25 (100%) 8 (33.3%) 
Week 3 Call 25 (100%) 10 (38.1%) 
Week 4 Call 25 (100%) 7 (28.6%) 
Seven day letter sent  25 (100.0%) 
 
 
37 
Table 3 
 
Analysis of APRN Subgroup of Dose Intervention on Outcomes  
 
Dose intervention 
group 
N 
(%) 
First 
appointment 
adherence 
30-day 
readmission 
Completed/validated 
study per outcome 
measure 
Call completions 
80% or greater 
10 
(45) 
50% 20% 100% first 
appointment 
adherence 
100% readmission 
Call completions 
Less than 80% 
12 
(55) 
42% 17% 50% in first 
appointment 
adherence 
83% readmission 
 
 
Participants that had an 80% or greater compliance with the phone call 
intervention showed a strong rate of  completing the study in its entirety compared to 
those participants that had a less than 80% compliance with phone call intervention 
completion.  Consistent with the overall outcomes of this study, the group that had a 
greater compliance with completing the phone call intervention had a higher percentage 
of attending their first outpatient appointment and a slightly higher percentage of 
requiring a readmission within 30 days.  However, for those individuals that did follow 
the 80% or greater phone completion intervention, readmission rates were 6% lower for 
that group (20%) compared to the entire intervention group (26.1%).  Readmission rates 
were flat for the group that did not complete the phone call intervention (17%) compared 
to the treatment as usual group (17.4%). 
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Analysis for Aim #2 
While not statistically significant, examination of first outpatient appointment 
adherence revealed that 63.2% (n=15) of the intervention group attended their first 
outpatient appointment compared to 57.9% (n=13) of the treatment as usual group. Thirty 
day readmission rates, while not statistically significant, identified a 26.1% (n= 6.0) rate 
for the intervention group compared to 17.4% (n= 4.0) readmission rate for the treatment 
as usual group.  Comparing self-report to medical record review showed that two 
participants stated that they attended their first outpatient appointment when the medical 
record identified that they cancelled their appointment.  One hundred percent of the 
readmissions were consistent between self-report and the medical record.  Tables 4 and 5 
highlight LOS and medication at discharge variables that demonstrated clinically 
meaningful differences between groups at baseline and that may have influenced 30-day 
readmission rates. 
 
Table 4 
 
Total Number of Meds at Discharge Per Group 
 
Measure N 
Mean 
(SD) 
95% CI 
Mean 
t- value p-value  
Total number of 
prescription meds 
at discharge 
   -2.40 .02  
TAU 23 6.30 
(3.59) 
2.72, 5.08    
Intervention 25 9.00 
(4.09) 
7.31, 10.69    
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Table 5 
 
Inpatient Length of Stay Per Group 
 
Measure N 
Mean 
(SD) 
95% CI 
Mean 
t- value p-value  
LOS days    -1.84 .07  
TAU 23 9.17 7.06, 11.29    
Intervention 25 13.00 9.27, 16.73    
 
 
Logistic regression was conducted comparing intervention groups to examine  the 
probability of attending the first outpatient appointment and 30-day readmission while 
controlling for length of stay, number of medications at discharge, race, marital status, 
and discharge diagnosis.  Wald odds ratios estimates and 95% confidence intervals were 
specified.  No statistically significant differences were observed between groups for 
readmissions and attendance at discharge appointment.   Tables 6 and 7 showcase the 
results of this evaluation. 
 
Table 6 
 
Logistic Regression for First Outpatient Appointment Adherence 
 
Variable name β SE 
95% CI 
estimate 
OR 
p-
value 
Intercept 1.060 1.20 -1.22, 3.65 2.88 .38 
Intervention group (TAU = ref) .250 .76 -1.25, 1.79 1.29 .74 
LOS -.020 .05 -.12, .09 .98 .75 
Total medications .009 .09 -.17, .20 1.01 .92 
Race (Caucasian = ref)  -.540 .95 -2.64, 1.26 .59 .58 
Marital status (married = ref) -.420 .79 -2.01, 1.15 .65 .59 
Discharge diagnosis (MDD = ref) -.240 .78 -1.78, 1.33 .78 .75 
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This model accounted for only 3.7% of the variance in attendance at the first 
outpatient appointment.  There were no statistically significant results; however, the 
findings are presented relative to direction of relationship to the outcome variable.  
Clinically, the intervention group was more likely to complete their outpatient 
appointment than the TAU group. Sub-group analysis results included:  
1. Clients with a shorter length of stay had a greater probability of attending their 
first outpatient appointment after controlling for intervention group, number of 
medications, marital status, race and discharge diagnosis; 
2.  Clients who had a higher number of medications prescribed at discharge had a 
higher probability of attending their first outpatient appointment after 
controlling for intervention group, LOS, marital status, race, and discharge 
diagnosis; 
3. Clients of minority descent had a lower probability of attending their first 
outpatient appointment than Caucasian clients after controlling for intervention 
group, number of medications, LOS, marital status, and discharge diagnosis; 
4.  Clients who were married had a higher probability of attending their first 
outpatient appointment than single clients after controlling for intervention 
group, number of medications, LOS, race, and discharge diagnosis; 
5. Clients who had a discharge diagnosis of major depressive disorder had a 
higher probability of attending their first outpatient appointment compared to a 
discharge diagnosis of bipolar after controlling for intervention group, number 
of medications, LOS, marital status, and race. 
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Table 7 
 
Logistic Regression for 30-Day Readmission Rate 
 
Variable name β SE 
95% CI 
estimate 
OR 
p-
value 
Intercept -1.56 1.08 -3.90, 0.46 .21 .15 
Intervention group (TAU = ref) .63 .86 -1.04, 2.42 1.88 .16 
LOS -.02 .06 -.15, .09 .98 .69 
Total medications .08 .10 -.11, .28 1.08 .40 
Race (Caucasian = ref)  -.92 .92 -2.77, .94 .40 .32 
Marital status (married = ref) 0.00 .86 -1.81, 1.65 1.00 1.00 
Discharge diagnosis (MDD = ref) .77 .81 -.86, 2.42 2.16 .35 
 
 
This model accounted for 11% of the variance in 30-day readmission rates.  There 
were no statistically significant results; however, the findings are presented relative to 
direction of relationship to the outcome variable.  The intervention group was more likely 
to be re-admitted than the TAU group.  Additional findings included: 
1. Clients with a shorter length of stay had a greater probability of being 
readmitted within 30 days after controlling for intervention group, number of 
medications, marital status, race, and discharge diagnosis; 
2. Clients who had a higher amount of total medications ordered at discharge had 
a higher probability of being readmitted within 30 days after controlling for 
intervention group, LOS, marital status, race, and discharge diagnosis;  
3. Clients of minority descent had a lower probability of being readmitted  
within 30 days than Caucasians after controlling for intervention group, 
number of medications, LOS, marital status, and discharge diagnosis; 
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4. Clients who were married had a higher probability of being readmitted within 
30 days than single clients;  
5. Clients admitted with major depressive disorder had a lower probability of 
being readmitted within 30 days than those diagnosed with bipolar after 
controlling for intervention group, number of medications, LOS, marital 
status, and race. 
An incremental cost-effectiveness ratio (ICER) analysis compared the differences 
between the direct and indirect costs of the intervention and the current discharge 
treatment as usual groups on hospital readmission within 30 days post-discharge.  The 
ICER numerator included the costs and the denominator included number of 
readmissions.  The ICER was computed as the difference in Costs/difference in 
Effectiveness (Readmissions).  The total cost for the treatment as usual group was 
$11,429.94 and $16,249.52 for the intervention group.  The ICER indicates a loss of 
$240.98 per patient when 30-day readmission is the outcome variable.  Table 8 highlights 
the measures evaluated for this ICER. 
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Table 8 
 
Incremental Cost-Effectiveness Ratio 
 
Cost Assumption Estimate Source 
Hospitalization 
(avg/day) 
 
Includes labs, 
EKG’s, nursing, 
drugs, medical 
supplies, bed 
charges. 
$1,053/day OSU Wexner Medical Center 
APRN intervention 
costs, parking, 
mileage 
60 minutes total 
intervention 
time/patient.  
Avg. visit = 2 
hours.  Federal 
standard 
mileage rate = 
56.5 cents/mile.  
Estimate an 
average of 30 
miles round trip. 
$7/day 
$16.95/day 
CampusParc 
NIH.gov 
Median income- 
Columbus 
$44,072 (2013) $169.50 http://quickfacts.census.gov/qfd/st
ates/39/3918000.html 
 
 
The last outcome variable assessed was the change in the participant’s quality of 
life scores from baseline to 30 days post discharge.  An independent t test compared the 
TAU and intervention groups on pre and post mean quality of life scores for each 
domain.  Results of the WHOQOL-BREF are listed below in Table 9.   Although not 
statistically significant, there was a clinically significant difference with a small to 
medium effect size of .345 pre-post between the groups on the physical domains, with the 
intervention group having a lower score. 
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Table 9 
 
Preliminary Effects: The World Health Quality of Life-BREF 
 
Measure 
n = 
pre/ 
post 
Pre-
mean/ 
post-
mean 
Pre SD/ 
Post SD 
t 
value 
p 
value 
Effect size 
*(Cohen's 
d) 
WHOQOL: BREF 
Physical domain 
Treatment as usual 
Intervention 
 
 
22/15 
24/14 
 
 
52.9/72.6 
52.9/55.4 
 
 
24.2/17.4 
19.7/24.3 
 
-1.138 
 
.261 
 
.345 
WHOQOL: BREF 
Psych domain 
Treatment as usual 
Intervention 
 
 
22/15 
24/14 
 
 
48.7/66.9 
37.8/48.2 
 
 
26.9/26.2 
23.6/28.3 
 
.165 
 
.870 
 
.050 
WHOQOL: BREF 
Social domain 
Treatment as usual 
Intervention 
 
 
22/15 
24/14 
 
 
54.2/66.7 
41.7/47.0 
 
 
26.4/27.6 
26.6/28.8 
 
.582 
 
.564 
 
.182 
WHOQOL: BREF 
Environment domain 
Treatment as usual 
Intervention 
 
 
22/15 
24/14 
 
 
 
58.5/71.0 
56.4/60.3 
 
 
21.9/19.5 
19.1/24.4 
 
.052 
 
.959 
 
.016 
Cronbach’s Alpha Pre: .924 
Cronbach’s Alpha Post: .951 
 
 
 Analysis for Aim #3 
The Revised Helping Alliance Questionnaire-Patient and Therapist Version were 
utilized to evaluate the significance of the interaction between the intervention participant 
and the APRN utilizing Pearson Chi Square.  Results of the significance of the 
interactions are listed in Table 10.  The questionnaire was completed at the 30 day mark 
of the study, with 10/25 surveys completed between the participant and the APRN.  Of 
the 10 surveys completed, all but one question identified no statistically significant 
difference in rating between the APRN and the participant.   
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Spearman rho correlations were analyzed to better understand relationships 
among key study variables. Significant correlations at the .05 and .01 level were 
identified in Table 11.  Participants that were discharged with significantly more total 
medication prescriptions were married.  Participants that had a higher inpatient length of 
stay were discharged with significantly more total medications at discharge than those 
with a shorter length of stay. 
  
Table 10 
 
The Revised Helping Alliance Questionnaire 
 
Question N (%) Pearson Chi 
1.  APRN and Pt 10 (40%) .217 
2.  APRN and Pt 10 (40%) .052* 
3.  APRN and Pt 10 (40%) .675 
4.  APRN and Pt 10 (40%) .868 
5.  APRN and Pt 10 (40%) .191 
6.  APRN and Pt 10 (40%) .280 
7.  APRN and Pt 10 (40%) .492 
8.  APRN and Pt 10 (40%) .121 
9.  APRN and Pt 10 (40%) .172 
10.  APRN and Pt 10 (40%) .273 
11.  APRN and Pt 10 (40%) .251 
12.  APRN and Pt 10 (40%) .385 
13.  APRN and Pt 10 (40%) .497 
14.  APRN and Pt 10 (40%) .644 
15.  APRN and Pt 10 (40%) .496 
16.  APRN and Pt 10 (40%) .579 
17.  APRN and Pt 10 (40%) .397 
18.  APRN and Pt 10 (40%) .302 
19.  APRN and Pt 10 (40%) .362 
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Table 11   
 
Variable Correlations 
  
 
 Race Marita
Status 
Discharge 
Diagnosis 
Total 
Meds at 
Discharge 
Readmit 
last 30 
days 
First 
appoint-
ment 
LOS 
     Race 1.00 .097 -.106 -.122 .136 .015 -.20 
Marita 
Status 
.097 1.00 -.024 .422** .126 -.163 .044 
  Discharge 
Diagnosis 
-.106 -.024 1.00 -.038 .110 -.078 .047 
  Total Meds 
at Discharge  
-.122 .422** -.038 1.00 .230 .002 .315* 
 Readmit 
last 30 days  
.136 .126 .110 .230 1.00 -.129 -.092 
First 
appoint-
ment 
.015 -.163 -.078 .002 -.129 1.00 -.114 
LOS -.200 .004 .047 .315* -.092 -.114 1.00 
 
** Correlation is significant at the .01 level (2-tailed), * Correlation is significant at the 
.05 level (2-tailed). 
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 Chapter 5: Discussion 
 
 
 Summary of Findings 
 
 The primary aim of this randomized, controlled pilot study was to test the 
feasibility, acceptability and preliminary efficacy of a psychiatric APRN to bridge adult 
inpatient to outpatient care to improve transition outcomes.  Preliminary effects measured 
were: (a) first outpatient appointment adherence, (b) 30-day readmission rate, (c) direct 
and indirect hospital costs related to readmission status, and (d) participant quality of life.  
Selected socio-demographic and alliance variables also were analyzed to determine 
significance as a first step in identifying potential mediators and moderators.   
 Interpretations of the findings are presented in this discussion chapter, along with 
limitations, implications for clinical practice and research and final conclusions. 
Feasibility and Acceptability 
 Utilizing APRNs in an academic medical center setting to provide a “bridge” to 
participants transitioning from inpatient psychiatric to outpatient psychiatric care was 
feasible for this pilot study and shows potential for future study expansion.  However, the 
telephone intervention proved to not be feasible, and thus, alternative recommendations 
are needed for future studies.  Administrative support and the provision of resources to 
examine patient treatment adherence were provided by the organization.  A research 
assistant was available to collect data for the study and four APRNs and a collaborating 
physician were budgeted and working in the system to provide intervention support.  
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Standardized scripting for the inpatient visit and phone calls and an electronic medical 
record allowed the intervention to have minimal variability in the provision and 
documentation of the intervention.  An unexpected threat to internal validity that 
occurred was the departure of two APRNs that resigned during the study.  This created a 
slight inconsistency with the intervention participant’s connection with their assigned 
APRN and an area that needs to be considered on how to adapt with future studies
 Patients on the adult inpatient units were eager to participate and contacted the PI 
directly after seeing study flyers to discuss the opportunity to enroll.  Recruitment of the 
study participants was faster than expected and refusal rate was extremely low with only 
two patients declining participation.  One of the highlights of this study was a “save” of 
an individual that was being followed on the intervention arm and had a consistent APRN 
for the 30 days post-discharge.  During one of the weekly calls, it was identified that the 
participant was not taking his medications appropriately and stated to the APRN that “he 
was preparing his yard and garden so that it looked nice for his funeral.”  As the APRN 
provided more phone support, he agreed to make an appointment with his counselor that 
day, pick up an updated prescription that the APRN was electronically sending to his 
pharmacy and the APRN updated the attending physician that cared for the patient during 
his hospitalization.  Due to this phone call and the intervention of this APRN, this 
participant’s life may have been saved.  An advantage of this intervention is that the 
APRN assessment is instrumental in the detection of potential problems that may be 
easily fixed with a phone call or may require immediate intervention that could involve 
re-hospitalization.  Therefore, early detection may lead to an increased need for 
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readmission.  This cannot be perceived as a failure of the study but rather the ability to 
potentially save a life and offer additional timely assistance. 
Retention of Participants 
  The interest garnered by the patients during the consent process indicated that 
compliance to answering their phone and participating in a short study post-discharge 
would not be a problem.  However, it became obvious that compliance for phone call 
follow-up was a major hurdle for this population of patients.  This issue may signify a 
maturational threat to internal validity as disease or cognitive changes/thoughts occurred 
over time with the participants and they failed to uphold their ability to participate.  
Although all participants were seen in the hospital prior to discharge, phone call 
completions dropped from a high of 52% compliance with the 24 hour safety call to 
28.6% compliance by week four, thus identifying that phone call follow-up with this 
population may not be feasible.  There also was a high study attrition rate with this 
participant sample as only 60% of the treatment as usual group and 56% of the 
intervention group completed 80% or greater of all aspects of the study.  Considerations 
for other mechanisms of communication and incentives for study completion are required 
for this type of follow-up for future studies.  There is a possibility that because the 
general hospital number appears on caller ID, participants may have ignored the call from 
the APRN thinking that it was related to their hospital bill.  Other options for 
consideration would be providing participants a calendar that has appointments entered, 
texting, FaceTime, walk in clinic, email communication, engaged involvement with 
supportive significant others or a dedicated number for the APRN so that clients are 
aware of who is calling.  Enhancement of the pre-discharge education between the APRN 
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and the patient/significant others on the importance of outpatient follow up may also 
increase the retention of the participants to the study objectives.  Further incentive 
options for participant retention could include a modest gift card at the completion of the 
study or entering participants who complete the study in a drawing for one modest 
“prize” at the end of the study. 
 The APRNs participating in the intervention found the feasibility of the program 
acceptable when they were only following 2-3 participants at any one time on top of their 
full- time job.  When the departure of the two APRNs occurred, the remaining APRNs 
had to follow a case load of 5-6 which became very time consuming and required 
additional work time that was not accounted for in the program. The ability to create 
dedicated positions on the bridge team that do not already have assigned responsibilities 
will allow commitment to the care of the participants during the transition period between 
inpatient and outpatient care.   
 Mortality of subjects to complete final survey requirements was an internal threat 
to validity.  While the acceptability goal of 80% completion of the study by all 
participants was not achieved (60% for the treatment as usual group and 56% for the 
intervention group) and the call completion percent was low for the intervention group, 
preliminary effects suggest that there may be opportunities to further enhance this 
intervention.  The subgroup analysis comparing participants that completed the 
calls/intervention greater than 80% of the time to those individuals that completed the 
intervention less than 80% of the time highlight the impact of the “dose response” on 
outcomes.  Even with a small sample size, individuals that engaged with their APRN and 
communicated per protocol showed a positive trend towards attending their first 
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outpatient appointment and requiring less re-hospitalization than those individuals that 
did not engage in the intervention consistently.  This analysis provides further interest in 
broadening the scope of study around this important dose response and impact with a 
larger sample size and longer follow up period.   
First Appointment Adherence Effects 
 While not statistically significant, it was found that the intervention group 
attended their first outpatient appointment at a higher percentage than the treatment as 
usual group.  The clinical significance of failure to immediately engage in outpatient care 
after hospitalization contributes to a higher risk of disengagement from treatment entirely 
and/or incites cause for readmissions/post-discharge and may make suicide a greater 
reality. Intervention participants were reminded of their appointment at discharge, at the 
24- hour safety call, the seven- day letter and weekly calls.  Anecdotally, the PI received 
two calls from participants stating that they had lost their letter but wanted to be 
reminded of their appointment time.  The APRNs were able to provide reminders to the 
participants of when their outpatient appointment was scheduled but it is unclear whether 
the participants had a strong understanding of why it was important to attend their first 
outpatient appointment.  For those participants that did not attend their first outpatient 
appointment, reasons provided were: (a) I was re-hospitalized; (b) I didn’t have a ride, (c) 
I forgot, and (d) didn’t feel it was necessary.  Additional options to consider with future 
studies may be sending a reminder text 24 hours prior to the appointment, adding social 
work assistance to the team to help with establishing transportation support, and 
enhanced discharge education on the importance of attending the first outpatient 
appointment.  The Bridge Team could be instrumental in helping current inpatients 
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realize the importance of post discharge follow up by offering patient groups on first 
appointment adherence while hospitalized and offering strategies on discharge planning. 
There was no statistically significant outcome related to first appointment adherence with 
the logistic regression analysis controlling for identified demographic variables.  (See 
further discussion in Potential Mediating/Moderating Variables section.)   
30-Day Readmission Effects 
Although the study was randomized, several baseline group differences were 
noted in clinically significant areas which may have contributed to the likelihood of 
readmission.  This unequal random allocation of participants was a threat to internal 
validity.  Examples include: (a) 80% of the intervention group had a discharge diagnosis 
of major depressive disorder versus 60.9% of the treatment as usual group, (b) Quality of 
life pre mean scores for all categories were lower or the same for the intervention group 
versus the control group, (c) total number of medications prescribed at discharge were 
significantly higher for the intervention group than the treatment as usual group, and (d) 
inpatient length of stay was significantly higher for the intervention group versus the 
treatment as usual group.  These data points highlight the clinically significant fact that 
more acute and medically complex participants were randomized to the intervention 
group. 
While not statistically different, the proportion of readmissions to an inpatient 
psychiatric unit within 30 days of discharge was higher for the intervention group than 
the treatment as usual group in this pilot study.  These results on the surface were 
disappointing as a primary effect of this bridge model was focused on providing 
resources and support to prevent hospital readmission.  There was no statistically 
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significant outcome related to 30-day readmission with the logistic regression analysis 
controlling for identified demographic variables.  (See further discussion in Potential 
Mediating/Moderating Variables section.)  However, correlation analysis did highlight 
the fact that married participants and those who had a longer inpatient length of stay were 
more likely to be discharged with more prescription medications. Additionally, 
individuals with more prescription medications and a longer inpatient length of stay were 
shown to be readmitted more frequently within 30 days.  These variables highlight the 
impact of medical complexity and benefits of social support on readmission rates in this 
patient population.   
Another area of consideration related to readmission status was the detection bias 
that occurred with the intervention group that was actually a positive impact.  The 
increased contact by the APRN with the participant allowed for detection of declining 
mental health status and need for more formal re-evaluation.  While this may have 
impacted readmission rates it was a positive impact for safe, patient care.  Future studies 
that provide longer follow-up (30, 60, 90 days) may allow for greater insight into the role 
of detection by the APRN with bridge strategies.  Another consideration to readmission is 
that initial inpatient treatment may begin with medication management and later be 
deemed as unsuccessful post- discharge.  Step approaches to care may require re-
hospitalization to change the medication regimen and/or add electroconvulsive therapy to 
the treatment plan.  Frequent monitoring through a bridge model may proactively detect 
needs and require the participant to be re-admitted.  A subgroup analysis comparing those 
participants that had an 80% or greater compliance to the phone call intervention versus 
the entire intervention group that may or may not have been compliant with the 
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intervention showed that the 80% or greater compliance group had a readmission rate 6% 
lower than the entire intervention group.  This is a positive clinical finding related to the 
importance of consistent follow-up through a bridge model and may be of statistical 
significance in larger sample studies. 
 This pilot research study was implemented at the academic medical center in this 
mid-western city that accepts medically complex psychiatric patients to their inpatient 
psychiatric unit.  This setting receives state funding to be the provider “of choice” to care 
for patients in the central Ohio area requiring extensive medical care along with the acute 
psychiatric diagnosis.  This department designation may have impacted the study results 
as a larger percentage of medically complex psychiatric patients are seen at this hospital 
versus the community psychiatric facilities.  This may have impacted the need for 
increased intervention and readmission in this pilot study.  Expanding this study to 
include other providers in the city would give a more realistic data set for this 
intervention as it would include all levels of psychiatric and medical acuity and support 
needed. 
 Utilizing a team approach to the Bridge Model may best provide for the multi-
disciplinary needs of this patient population.  Maximizing the role of the APRN in 
chronic medical care and medication management follow-up, a Nurse Navigator for case 
management needs and a licensed independent Social Worker for the various social, 
housing, transportation and criminal justice support could better meet the expectations 
and provide more intense outpatient support. 
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Direct and Indirect Costs Effects 
 There was a statistically significant difference in length of stay upon enrollment in 
the study between the intervention group (M = 13, SD = 9.03) and the treatment- as- 
usual group (M = 9.17, SD = 4.90) which influenced the results of the preliminary cost-
effectiveness analysis.  The total cost for the treatment as usual group was $11,429.94 
and $16,249.52 for the intervention group.  Seventeen percent of the treatment- as- usual 
participants and 26% of the intervention participants was re-admitted within 30 days 
post-discharge.  Thus, the ICER of $240.98 indicates that there is a loss of approximately 
$241/patient for the APRN program when 30-day readmission is the outcome variable.  
This outcome was not expected in the intervention planning, however, future studies with 
larger data sets and medical complexity control may provide a more positive outcome for 
direct and indirect costs.  Considerations to review a 1 year secondary data set of costs 
for patients that require medical care after a suicide attempt versus proactive bridge 
planning and readmission as necessary may highlight an overall reduction in direct and 
indirect cost with this intervention. 
Quality of Life Effects 
 The World Health Organization Quality of Life-BREF tool was given to all 
participants at baseline and at the 30 day mark of the study.  Pre- and post-domains were 
calculated for each participant in the categories of physical, psychological, social, and 
environmental aspects of quality of life.  While there were no statistically significant 
differences between the treatment- as- usual group and the intervention group at baseline 
and post, there was a clinically significant difference with the physical domains of the 
groups.  The largest mean differences were found in this domain with a small effect size 
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noted for this category.  This aligns with the fact that the intervention group required 
more medications at discharge and required a longer inpatient length of stay.  Baseline 
quality of life indicators were higher for the treatment as usual groups in all domains 
except physical.  The physical domain means were virtually equivalent between groups at 
baseline.  A positive indicator of this study was that both groups showed improvement in 
all scores from baseline to 30 days post study.  The post-mean scores of the intervention 
group in all domains, however, were lower than the post-mean scores of the treatment as 
usual group.  It is unclear as to why there was positive improvement in all categories 
between groups and why the TAU group scored higher but likely that the inpatient stay, 
medication adjustments, and therapy provided larger improvements in the less medically 
complex participants than those with more complex needs.  The TAU group may have 
required simpler treatment plans than the intervention group to improve their quality of 
life metrics.   This tool showed adequate reliability utilizing Cronbach’s alpha analysis at 
both pre- and post-survey.  Utilization of this tool for future expanded studies and 
associated larger sample sizes would provide greater insight into the quality of life needs 
for this population. 
 Results of this quality of life analysis support the need for continued APRN 
support for these participants with medically complex needs and medication management 
support post-discharge.  The addition of a social worker to this treatment team may assist 
in the social support factors to enhance this domain of quality of life. 
 The Revised Helping Alliance Questionnaire was given to the intervention 
participants and the APRN associated with their interaction at day 31 of the study by the 
PI.  The purpose of the information garnered from this survey was to evaluate the 
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correlation between the patient score and the APRN score on 19 questions of the survey.  
The alliance “goal” would be that the APRN and the participant were aligned with the 
relationship that formed in the 30 days of the study.  This alliance also assists with the 
ability to detect problems that are said and not said between the participant and APRN.  
Utilizing an alliance tool for this intervention may assist in determining whether the 
scripted intervention or the intervention and the relationship between the APRN and 
participant made a difference in outcomes.  A stronger relationship (alliance) between the 
APRN and participant may increase the “ownership” to communicate and follow-up and 
thus have the ability to improve overall outcomes.  Due to the small sample size and 
incomplete surveys, it is unclear as to whether the alliance made a difference in this pilot 
study.   Comparing scores of the participants and the APRNs showed that there was no 
significant difference in scoring except for question #2.  Participant question #2, “I feel 
the therapist understands me” and APRN question #2, “he/she feels I understand 
him/her” had a significant difference in scoring.  Cronbach’s alpha was borderline 
acceptable for the participant and therapist version at .796 and .724, respectively.  There 
was a positive verbal acceptance of the program by the participant’s that completed the 
30-day follow-up surveys.  A limitation to this questionnaire was the low sample size.  
Further expansion of sample size needs to be obtained to provide overall reliable and 
stable scoring and evaluation for this tool. 
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Potential Mediating/Moderating Variables 
There were no statistically significant differences in the demographic variables at 
baseline of the sample and analyses that controlled for length of stay, total meds at 
discharge, race, marital status, and discharge diagnosis on key outcomes. 
However, medications at discharge and length of inpatient stay were evaluated 
between treatment as usual and the intervention group.  Both statistically and clinically 
significant differences were observed with total number of meds prescribed at discharge 
between the treatment- as- usual and the intervention group.  Although significance was 
not observed for differences in numbers of antipsychotics or antidepressants prescribed, 
the strong statistical and clinical significance was in the amount of medications 
prescribed related to respiratory, cardiac, and glycemic medication control.  Participants 
discharged with additional respiratory, cardiac, and glycemic meds reinforces a strong 
emphasis towards co-morbidity concerns with the intervention group.  Participants in this 
group may not have the financial means to fill all the prescriptions that were ordered at 
discharge, lack adherence to the overall medication and treatment plan, and not take the 
ordered medications to avoid the physiological complications and interactions of the 
various medications that may impact overall quality of life.  Adherence to medication 
management is a strong area of focus for these patients to improve quality of life and 
prevent complications/need for readmission. 
 The length of inpatient stay was statistically and clinically longer for the 
intervention group compared to the treatment as usual group.  The needs of the 
intervention population required a longer mean hospitalization for the intervention 
variables than the treatment as usual group.  There were no significant differences in the 
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intervention variables than the treatment- as- usual group.  Regulating the acute 
psychiatric issues with the various medical complexity and social needs of this 
intervention group impacted the length of stay.  Ensuring adequate post discharge 
housing, extended care facility placement, medical equipment needs, diabetic and wound 
care teaching and support may have impacted length of stay. 
 Logistic regression analyses were completed to evaluate direction of relationships 
between the intervention and treatment as usual groups on first outpatient appointment 
adherence and 30-day readmission rates while controlling for several socio-demographic 
variables and the intervention.  The regression models accounted for a low variance in 
first outpatient appointment adherence and 30-day readmission.  While not statistically 
significant, the intervention group was more likely to complete their first outpatient 
appointment than the TAU group but was also more likely to be readmitted.  This may 
account for the concept that improved detection may inadvertently increase the 
readmission potential. 
 Clients that had a lower length of inpatient stay while controlling for the 
intervention group, number of medications, marital status, and discharge diagnosis had a 
greater probability of attending their first outpatient appointment but a greater possibility 
of being readmitted within 30 days.  This again highlights the importance of early 
detection and may also trigger a consideration on whether these clients were discharged 
too soon from inpatient care for their required needs. 
 Clients that had a higher number of medications prescribed at discharge after 
controlling for intervention group, LOS, marital status, race and discharge diagnosis had 
a higher probability of attending their first outpatient appointment and being readmitted 
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within 30 days.  Co-morbid conditions that place clients at greater risk for medical and 
psychiatric instability are often controlled with more complex medication regimes.  
Stabilizing dosage requirements and ensuring compliance with medication management 
are known issues with this patient population.  Maximizing the utilization of an APRN to 
bridge care and encourage medication adherence is a potential strength of this model.   
 Clients of minority descent had a lower probability of attending their first 
outpatient appointment and a lower probability of being readmitted than Caucasians after 
controlling for the intervention, number of medications, LOS, marital status, and 
discharge diagnosis.  This is not an uncommon finding as cultures and stigma related to 
beliefs regarding mental illness do not always allow for minorities to adhere to mental 
health treatment planning. Increasing minority advanced practice nursing and community 
outreach for this population may help to improve treatment adherence. 
 Clients that were married had a higher probability of attending their first 
outpatient appointment and being readmitted within 30 days than single clients while 
controlling for intervention, number of medications, LOS, race, and discharge diagnosis.  
This may be explained by the importance of social relations being available for this 
patient population to encourage and support treatment planning adherence and being a 
resource to assist patients requiring additional stepped care. 
 Clients that had a discharge diagnosis of major depressive disorder had a higher 
probability of attending their first outpatient appointment and a lower probability of 
requiring 30-day readmission than a diagnosis of bipolar after controlling for intervention 
group, number of medications, LOS, marital status, and race.  This is not an unusual 
finding as individuals with bipolar disease may require more frequent follow-up for 
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medication adjustments and therapeutic interventions.  APRN detection with these cases 
may assist in more prompt intervention. 
 The Revised Helping Alliance Questionnaire was a measure that was utilized for 
the intervention participants and APRN’s to determine potential alliance metrics and 
significance of the forming relationship.  While the completion sample size (n=10) does 
not allow for any generalizable impressions, the positive trending between how the 
APRN and the participant felt about the relationship may indicate that for those that 
maintained a “strong dose” of the intervention, the relationship formed was healthy and 
sustainable and may impact future adherence to care. 
 Limitations 
 Although this study has strengths associated with a randomized, controlled 
design, the results from this study should be interpreted with caution because limitations 
to the intervention and study demographics create validity and generalizability issues 
with the findings.  The inclusion criteria for the study were restricted to major depressive 
disorder and bipolar adult patients that did not have an active suicide attempt prior to 
admission to the inpatient psychiatric facility.  This criterion was restrictive on the types 
of participants that may or may not have benefitted from the intervention.  Over 60% of 
all participants were Caucasian and 100% were non-Hispanic; thus, racial and ethnic 
minority groups were not represented well in this sample.  Medical complexity was not 
controlled for in this study and may be an area for consideration in future studies. 
 Although recruitment for the study was relatively effortless, final completion rates 
by both the treatment as usual and intervention groups were not as high as expected.  
Follow-up with participants to answer phone calls and complete final surveys was 
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difficult and did not provide the amount of data expected to make statistically significant 
assumptions.  A gift card incentive was provided to all participants on the day of 
discharge for their acceptance to be in the study.  Possibly offering a second gift card for 
participating in the post-intervention survey may assist in improving completion rates for 
phone calls and post-study surveys. 
 The turnover of two APRNs during this study impacted the consistency of the 
intervention participants because they had to switch to a different APRN mid- study.  
While it is unclear as to the definite impact of this, it can be assumed that there may be 
therapeutic alliance issues with not having consistency with the pairing.  Another 
limitation to this turnover issue is that the remaining two APRNs had to carry a larger 
load of patients and this was in addition to their full -time work schedules.  Having the 
ability to dedicate APRN time to this study may have improved the ability to contact and 
communicate more effectively with the participants.  Considering the multiple social 
needs of this patient population, adding a licensed independent social worker to the team 
may improve the distribution of the workload and better serve the social needs of this 
population. 
 In depth statistical analysis of study group variables, correlations and regression 
opportunities were limited with the small sample size.  Future large scale studies will 
improve the ability to evaluate statistical significance more effectively.  However, 
clinical efficacy was achieved on several outcomes measured and will allow the 
researcher to consider significance in future studies. 
 Emphasis will need to be placed on mechanisms for how this intervention can be 
cost effective and reduce readmissions to be administratively accepted.  While a case can 
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be made that “bridge detection” may influence a greater opportunity for patients to be re-
admitted, the cost of saving a life or the astounding medical costs of a failed suicide 
attempt may be more important than the readmission metric (e.g. example presented of 
APRN follow-up call). 
 Implications for Clinical Practice 
 Defining a clinically meaningful change in practice and the methods for 
implementation has been discussed in the literature, most extensively around health-
related quality of life.  From the patient point of view, a meaningful change may be “one 
that results in a meaningful reduction in symptoms or improvement in function” (Crosby, 
Kolotkin, & Williams, 2003, p. 396).  From a statistical significance, “the difference 
depends not only on the magnitude of the change itself, but also on the sample size and 
the variability of the measure” (Crosby et al., 2003, p. 400).  Lastly, “an effect size can 
represent a standardized measure of change over time by calculating pre- and post-mean 
differences and dividing by the standard deviation of the pre-test” (Crosby et al., 2003, p. 
400).  Taking the perspectives of these change definitions allows for clinicians to utilize 
research findings to make clinically relevant decisions on care delivery. 
 During the consent process of this pilot study, the voice of the “customer” 
included more times than not the importance of having a “transition resource” available 
post-discharge.  Participants talked about having a resource to help with medication 
management, housing, and just someone to talk to when they needed a lift in spirits.  
While it was not clear as to the level of role needed or how the communication link 
should flow, clinical support was assumed.  Several participants asked if the APRN could 
make home visits and this was explained as not part of the current study protocol. 
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 Understanding the rationale for the readmission need is another area of clinical 
focus in upcoming studies.  Secondary data analysis regarding medical complexity and 
stepwise approaches to care (e.g., medication failure to electroconvulsive therapy) is 
needed.  Incorporating an understanding of how the alliance of the APRN/participant 
relationship increases detection of needs may explain a higher readmission risk but a 
greater improvement in life threatening complications that would go untreated without 
intervention. 
 Recommendations for advancing this protocol into clinical practice are the 
following: 
 Disseminate findings of the pilot study through the Journal of the American 
Psychiatric Nurses Association. 
 Disseminate findings to the hospital organizations and the psychiatric professional 
organizations that provide inpatient, outpatient and emergency psychiatric care. 
 Develop a dedicated “bridge team” that incorporates a physician, APRN, Nurse 
Navigator and social worker to follow-up with discharged adult psychiatric patients 24 
hours after discharge and weekly until their first outpatient appointment.  Organizations 
should consider high risk patients that may benefit more strongly from the intervention 
and routes of communication, consider results from future multi-site research studies to 
guide planning and implementation. 
 Collaborate with the inpatient service and the psychiatric emergency services at 
hospital organizations to determine treatment planning options that communicate with the 
bridge team to provide safe alternatives to hospital readmission. 
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 Educate outpatient providers about the organization’s bridge program process and 
identify collaboration efforts between the two systems. 
 Educate patients and their families on the bridge program process and how best to 
utilize the resources provided. 
Investigate other technological devices and face to face options for 
communication between APRN and client that are more effective than phone calls. 
 Implications for Future Research 
 The results of this pilot study will inform the design for future large scale, multi-
site randomized studies.  Future research protocols will include dedicated team members 
to support the research outside of their current roles.  The addition of a social worker to 
the bridge protocol will allow for additional resources to be utilized assisting with 
housing and transportation needs that impact arriving to the outpatient appointments and 
better support to prevent readmission.  Considerations of utilizing a Nurse Navigator role 
vs. an APRN for routine follow up may be a more cost effective consideration with future 
studies.  An APRN could continue to collaborate with the team on more chronic cases 
involving medication management and chronic medical health needs.  Evaluating options 
other than a telephone call for participant communication should be considered with 
future protocol planning.  This may be as simple as text messaging and as rigorous as a 
home visit or walk in clinic style planning.  Providing incentives at the beginning and 
post-intervention of the study may assist in greater study completion rates. 
 Further evaluation needs to be considered related to moderators and mediators.  
Variables that were not studied in this pilot study that should be considered are: housing 
stability, substance abuse, involvement in the criminal justice system, community linkage 
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support and social support.  Continued evaluation of the role of the therapeutic alliance 
between the bridge team and the participant versus the actual communication intervention 
should be further evaluated.   
 Medical complexity as it relates to the type and number of discharge medications 
and inpatient length of stay were two variables that were not expected to be significant 
but became relevant between the treatment- as- usual and intervention group.  
Randomization with this small sample size did not help in this particular study as more 
acute participants were found to be in the intervention arm versus the treatment as usual 
group. 
 Extending the study length to gather information at 30, 60 and 90 days would be 
helpful in determining outcomes for outpatient follow-up, readmission status, overall 
direct and indirect costs estimates and quality of life.  This may allow both researchers 
and clinicians to understand vulnerable time slots where support is most needed for this 
population. 
 Future RO1 grant funded studies that expand the sample size will allow for a 
more robust data analysis of the variables being measured and will be a goal of this 
researcher.  Studies utilizing more sophisticated statistical methods (e.g., SEM) would be 
very helpful in determining more significant considerations as to the “whys” of the 
research aims and the process for “how” the intervention works. 
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 Conclusions 
 The evaluation of care transitions in healthcare is a significant area of focus for 
improving treatment adherence, preventing hospital readmission and reducing 
complications.  Ensuring that clients have the necessary social, environmental, and 
medical supports to decrease the vulnerability of a healthy transition between inpatient 
and outpatient care is especially critical for the adult psychiatric population.  Research 
has shown the efficacy of utilizing APRNs to “bridge” the gap of care in patients with 
chronic medical conditions; however, there is little evidence on how this role can be of 
importance with the mental health population.  This randomized, controlled pilot study is 
one of a few research studies that have evaluated the preliminary effects of utilizing this 
intervention in patients with major depressive disorder and bipolar diagnosis.  The APRN 
bridge model demonstrated to be a feasible consideration for this population of patients 
but will require a new intervention that is more feasible than telephone calls. 
Acceptability of the model was not statistically significant but qualitative indications 
suggest that patients believe this role is important.  The use of various technologies for 
contact with this population post-discharge is an area to re-evaluate in future studies to 
improve the acceptability goals. 
 Intervention participants in this study appeared to have more medical co-
morbidities, lower quality of life scores and overall higher acuity than the treatment as 
usual group.  This impacted the ability to adequately compare whether this intervention 
had the ability to reduce readmission rates in this patient population.  It is interesting to 
note that in the small subgroup of individuals that had a higher compliance to the phone 
call intervention that their readmission rate was lower than the entire intervention group 
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that had inconsistent compliance with the phone call intervention.  This may indicate that 
further exploration of more appropriate communication links may actually have a 
positive impact on this outcome metric.  An additional consideration could be made that 
the readmission was a positive outcome as the APRN was able to assist with detection of 
issues that may have not come to light without the intervention of the APRN following 
up with the participant and ensuring a safe plan of care.  While not statistically 
significant, the intervention participants did show a higher percentage of attending their 
first outpatient appointment.  Various intervention strategies that were part of the 
inpatient visits, calls and seven day letter served as reminders for this important metric 
and appeared to be clinically significant for the intervention group. 
 Expanding the current study to involve multiple community inpatient psychiatric 
units, utilizing a team approach to bridge the plan of care with dedicated APRNs/social 
workers and collaborating physicians, improving the technology communication 
available for clients and controlling for the medical complexities of this population will 
enhance the study design and offer additional support to this group of patients.  
Transitioning this vulnerable population to a more healthy and sustainable life is an 
important goal with this study and future expanded studies in bridging the gap of care 
delivery for mental health.  
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Review of the Literature 
 
CITATION OVERVIEW/DESIGN STRENGTHS LIMITATIONS 
APPLICABILITY TO PRACTICE: 
OUTCOMES MEASURED AND 
FINDINGS 
Nelson, E. Anne, 
Maruish, Mark E., 
& Axler, Joel L. 
(2000).  Effects of 
Discharge Planning 
and Compliance 
with Outpatient 
Appointments on 
Readmission Rates. 
Psychiatric 
Services, 51(7), 
885-889.  
This secondary data 
assessment study 
examined whether 
psychiatric patients 
discharged from 
inpatient care would 
have lower re-
hospitalization rates if 
they kept an outpatient 
follow-up appointment 
after discharge.  Of the 
3,113 psychiatric 
patients followed, 542 
were re-hospitalized.  
Patients who did not 
have an outpatient 
appointment were 2x 
more likely to be re-
hospitalized in the same 
year than those who kept 
an appointment. 
*The study supports 
benefits of continued 
outpatient care related 
to re-hospitalization. 
*Noncompliance with 
outpatient follow-up 
is a strong predictor 
of readmission. 
*Study focused on 
the psychiatric patient 
population. 
*The study did not account 
for severity levels of care 
and medically complex 
readmissions. 
*The study did not control 
for the type of outpatient 
appointment. 
*The study did not control 
for time variances to 
achieve first appointment. 
*The study did not 
examine an APRN role to 
assist with discharge 
transition. 
 
*Study examined key indicators of: first 
appointment adherence and  
readmission rates. 
*Aggregated annual rates based on this 
study indicate that patients who keep 
appointments had a one in ten chance of 
being re-hospitalized, whereas those who 
did not had a one in four chance. 
Reynolds, W., 
Lauder, W., 
Sharkey, S., 
Maciver, S., Veitch, 
T. & Cameron, D. 
(2004). The effects 
of a transitional 
This pilot RCT 
evaluated an intervention 
called “transitional 
discharge” compared to 
the current usual 
discharge process of the 
institution.  The sample 
*Study focuses on the 
psychiatric patient 
population. 
*Utilized valid and 
reliable tools- QOL 
Brief Version Scale 
and Colorado Client 
*Small sample size with 
pilot study- needs 
replicated with larger 
sample size, multisite. 
*Utilized inpatient RN’s to 
provide the support post 
discharge vs. the use of 
*Study examined key indicators of hospital 
readmission and quality of life. 
*Provides an impetus for future larger scale 
study. 
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discharge model for 
psychiatric patients.  
Journal of 
Psychiatric and 
Mental Health 
Nursing, 11, 82-88. 
 
was 25 patients who 
were discharged from 
an inpatient setting 
during a 3 month 
period.  14 were 
randomized to the 
control group and 11 to 
the intervention group.  
The intervention model 
included peer support 
and an overlap of 
inpatient and community 
staff to link with the 
discharged patient during 
the transition of care.  
Outcomes of the study 
showed:  decrease 
symptoms and increased 
level of functioning with 
both the control and 
intervention group. 
Increased quality of life 
and decreased 
readmission were seen in 
the intervention group.  
Control group was 2x 
more likely to be 
readmitted than 
intervention group. 
Assessment Record. 
*Interventional RCT 
model. 
 
APRN’s- may have 
contributed to the lack of 
change between control 
and intervention groups on 
symptom severity and level 
of functioning. 
*Training plan for team 
was weak- only identified a 
one day education session. 
Wortans, J., 
Happell, B. & 
Johnstone, H.  
(2006). The role of 
the nurse 
practitioner in 
Qualitative, 
exploratory study of 
individuals who had 
received care and 
treatment provided by a 
Nurse Practitioner 
*Adds to the limited 
body of knowledge 
related to Psych NP 
role in outcomes and 
satisfaction of care. 
*Supports the 
*Small sample size, 7. 
*Reports of this study are 
based only on one NP 
candidate- cannot 
confidently identify if the 
positive comments related 
*Study examined key indicators of the role 
of the NP in quality of care. 
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psychiatric/mental 
health nursing:  
exploring consumer 
satisfaction.  
Journal of 
Psychiatric and 
Mental Health 
Nursing, 13, 78-84. 
 
candidate to assess 
satisfaction of care. 
Individual interviews 
were conducted with 
consumers who had 
received care and 
treatment provided by 
the NP candidate.   The 
study contributes to the 
limited body of 
knowledge in 
psych/mental health 
nursing by emphasizing 
the importance of the 
relationship between the 
NP and the consumer in 
facilitating care and 
treatment.  Findings of 
this small scale study 
support the idea that 
consumer satisfaction 
with NP services is high 
or at least equivalent to 
that of a medical 
practitioner. 
importance of a 
therapeutic 
relationship between 
provider and patient-
significant function of 
a psychiatric nurse. 
*Supports need for 
future quantitative 
research highlighting 
significant outcomes 
of a psychiatric NP. 
 
to the role of the NP are to 
this one individual or to the 
role of the NP. 
Rose, Linda, 
Gerson, Linda & 
Carbo, Cynthia.  
(2007). Transitional 
care for seriously 
mentally ill persons:  
a pilot study. 
Archives of 
Psychiatric Nursing, 
21(6), 297-308. 
Qualitative pilot study 
with a sample of 10 to 
evaluate a nurse based in 
home transitional care 
intervention for seriously 
mentally ill persons.  The 
intervention focused on 
med teaching and family 
support.  The setting was 
in a large urban region 
*Cultural variation 
with using African 
American population 
in study. 
*Utilized an APRN 
for the home 
studies/interviews. 
*Identified themes for 
future study relevant 
to the role of the 
*Small sample size- 10. 
*Lacked a control group. 
*Lacked a teaching plan 
and structure for how 
interviews were conducted.  
Very individualized- 
fidelity of the study themes 
are at risk. 
*Results based on one 
APRN. 
*Identified themes can assist with protocol 
development for future RCT’s.  Highlights 
the unique role of the APRN in education 
and support. 
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with a majority African 
American population.  
Recruitment conducted 
while patient was an 
inpatient and APRN met 
with the patient prior to 
discharge and was 
followed with a home 
visit in 48 hours and four 
additional visits in the 
next 6 weeks.  Detailed 
logs were kept by the 
APRN’s on the education 
and health related 
discussions completed 
with each participant.  
General themes of key 
areas were identified for 
future inclusion of 
RCT’s.  Themes 
included:  Caregiver 
health status, daily 
structure and physical 
activity and medication 
adherence. 
APRN. *Future RCT needed with 
larger sample size to 
evaluate program. 
*Outcomes needed to 
support model. 
Burns, T., Catty, J., 
White, S., Clement, 
S., Ellis, G., Jones, 
I.R., Lissouba, P., 
McLaren, S., Rose, 
D. & Wykes, T.  
(2009). Continuity 
of care in mental 
health:  
understanding and 
The aim of this study 
was to operationalize a 
multi-axial model of 
continuity of care and to 
use factor analysis to 
determine its validity for 
the severally mentally ill 
population.  Seven 
factors that accounted 
for 62.5% of the total 
*Provides a starting 
point of key areas of 
focus that are 
important to this 
patient population 
with continuity of 
care transition. 
*Future research 
needed to confirm 
factors. 
*Methods and tools did not 
identify validity and 
reliability of instruments. 
*Protocol for the interview 
sessions was non-existent- 
difficult to determine who 
and how the interview 
process was occurring. 
*Focused entirely on 
outpatients. 
Provides factors for the APRN to 
incorporate into protocols for maximizing 
needs of transitional care with this 
population. 
 7
8
 
measuring a 
complex 
phenomenon.  
Psychological 
Medicine, 39, 313-
323. 
 
variance that were 
important for 
continuity of care in this 
study:  experience and 
relationships, regularity, 
medication management, 
consolidation of care, 
managed transitions, care 
coordination and 
supported living.  108 
service users who met 
the inclusion criteria of 
having long-term 
psychotic disorders 
were interviewed with 
the use of several tools:  
The Camberwell 
Assessment of Need, 
Scale to Assess 
Therapeutic 
Relationships in 
Community Mental 
Health Care and 
Demographic records. 
*Study was aimed at 
severally mentally ill- 
limited current 
knowledge. 
*Results may indicated a 
selection bias- those who 
agreed to participate may 
be much more engaged in 
the process towards 
improved services than 
those who did not 
participate. 
Batscha, Catherine, 
McDevitt, Judith, 
Weiden, Peter & 
Dancy, Barbara.  
(2011). The effect 
of an inpatient 
transition 
intervention on 
attendance at the 
first appointment 
postdischarge from 
*One group prospective 
pilot study exploring 
feasibility, outcomes and 
cost of an APRN 
transitions intervention 
from an inpatient 
psychiatric facility to 
attendance at first 
postdischarge 
appointment.  Findings 
showed that contact with 
*Based on the 
Transitional Care 
Model (Naylor) and 
the Care Transitions 
Model (Coleman). 
*Low cost 
intervention to 
implement 
*APRN meets with 
inpatients before 
discharge to establish 
*One group prospective 
design- no control group.  
Cannot determine true 
effectiveness of 
intervention. 
*Small sample size-15. 
*Limited to DSM-IV axis 
one disorders. 
*Recruitment may show a 
self-selection bias- those 
who consented may be 
*Research is focused on first appointment 
adherence.  Serves as an impetus for future 
RCT studies to expand on knowledge. 
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a psychiatric 
hospitalization.  
Journal of the 
American 
Psychiatric Nurses 
Association, 17(5), 
330-338. 
a clinician who can 
bridge the gap between 
discharge and the first 
post discharge 
appointment is feasible 
and may be helpful in 
increased attendance 
rates.  Sample size was 
15 patients.  Results 
showed that 92% of the 
patients in the study 
attended their first 
appointment vs. the 
previous usual care of 
44%.  The study 
intervention consisted of 
three tools: (1) a 
predischarge transition 
interview, (2) an 
appointment reminder 
letter and (3) a brief 
meeting at the first post 
discharge appointment. 
relationship, provides 
tools and follows 
patient through first 
appointment. 
*Feasible to conduct 
further RCT 
intervention studies to 
evaluate cost 
effectiveness and 
quality outcome 
metrics. 
more likely to be engaged 
and attend appointments 
than those who did not 
consent. 
*The Discharge Issues 
Assessment Tool was 
developed by the 
investigator and utilized in 
this study.  However, there 
is no evidence that this tool 
has been proven to be valid 
and reliable for use. 
Skarsater, Ingela & 
Willman, Ania.  
(2006). The 
recovery process in 
major depression:  
an analysis 
employing Meleis’ 
transition 
framework for 
deeper 
understanding as a 
foundation for 
The purpose of this 
secondary analysis of 
men and women 
recovering from 
depression, and had been 
an inpatient for at least 
48 hours, was to gain a 
deeper understanding of 
the concept of transition 
in the recovery process.  
Sample size- 25.  
Interviews conducted on 
*Provided insight as 
to the key concepts of 
transition and 
psychiatric nursing 
interventions that can 
assist in the recovery 
process. 
*Descriptive study only 
*Transcriptions of 
interviews were used to 
form themes and 
subthemes- no clear 
understanding of 
methodology of approach 
and fidelity of who was 
asking questions and 
protocol. 
*Study needs to be 
replicated and information 
* Provides potential concepts to consider 
when creating protocol for a transition plan 
with patients being discharged with major 
depression. 
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nursing 
interventions.  
Advances in 
Nursing Science, 
29(3), 245-259. 
the participants of the 
study involved one 
question “What helped 
you recover from 
depression?” 
presented in a statistically 
sound manner, such as 
factor analysis for 
consideration. 
Steffen, S., Kosters, 
M., Becker, T., & 
Puschner, B. (2009).  
Discharge planning 
in mental health 
care:  a systematic 
review of the recent 
literature.  ACTA 
Psychiatrica 
Scandinavica, 120, 
1-9. 
A systematic review and 
meta analysis identified 
11 studies in 13 years 
and cumulated sample 
size of 5655 participants 
that determined the 
efficacy of discharge 
planning interventions in 
mental health care from 
inpatient to outpatient 
treatment on improving 
patient outcome, 
ensuring community 
tenure and saving costs.  
Of the eleven studies, six 
were RCT’s, three were 
controlled clinical trials 
and two were cohort 
studies.   Overall, the 
studies showed that 
discharge interventions, 
mostly related to 
preparation during 
inpatient treatment are 
effective in reducing re-
hospitalization and 
improving adherence to 
aftercare.  
*Pooled estimates for 
readmission revealed 
a risk ratio 
significantly in favor 
of the studies with an 
intervention related to 
discharge planning.  
Also adherence to 
outpatient services 
resulted in a 
considerable 
advantage to the 
intervention groups. 
*Difficult to ensure that all 
studies were defining 
“discharge planning” in the 
same capacity 
*No control for psychiatric 
diagnosis or severity in 
study participants- this may 
lead to a wide variation in 
post discharge problems. 
*Very few trials have been 
published in this area, small 
sample sizes and small 
number of trials of high 
level evidence. 
*Further exemplifies need for high level 
evidence studies in this area of focus. 
Taylor, C., The purpose  of this *The study supports *Data was collected from *Study examined bridge strategies that 
 8
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Holsinger, B., 
Flanagan, J.V., 
Ayers, A.M., 
Hutchison, S.L. & 
Terhorst, L.  (2014). 
Effectiveness of a 
brief care 
management 
intervention for 
reducing psychiatric 
hospitalization 
readmissions.  
Journal of 
Behavioral Health 
Services & 
Research, 1-9. 
quasi-experimental, two 
group  design (one 
group assigned to 
interview intervention 
and one group assigned 
to usual care) examines a 
recovery-focused care 
management bridging 
strategy implemented 
during inpatient 
psychiatric stay with the 
goal to increase 
engagement in aftercare 
and reduce psychiatric 
readmission.  87 
individuals were assigned 
to the intervention group 
and 108 to the control 
group.  The on site 
intervention was a one 
time semi structured 
interview which 
discussed barriers to 
outpatient care and use of 
a crisis plan.  Care 
Managers of a 
Behavioral Health Care 
Organization completed 
the interviews on patients 
that were readmitted 
within 30 days to a 
psychiatric inpatient 
hospital.  After 
controlling for age, living 
situation and utilization, 
the use of bridging 
strategies that are 
initiated prior to 
discharge for high 
risk mental health 
patients to reduce 
readmission rates. 
*Study focused on the 
psychiatric patient 
population. 
 
only one psychiatric 
facility- unable to 
generalize the findings. 
*Individuals were assigned 
to groups vs. being 
randomized. 
*The study did not control 
for severity of disease or 
co-morbid conditions. 
*Limited to only 30 day 
readmission. 
*Care Managers were not 
blinded to the participants. 
*Did not use APRN. 
involve inpatient discharge planning and the 
impact on 30 day readmission rates. 
*Study focused on the importance of 
building a rapport between the care 
manager and the patient. 
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individuals in the control 
group were 2x more 
likely to be readmitted 
within 30 days of an 
index readmission than 
individuals that received 
the intervention. 
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 APPENDIX B: THE WORLD HEALTH ORGANIZATION QUALITY 
 OF LIFE-BREF 
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The following questions ask how you feel about your quality of life, health, or other areas of 
your life. I will read out each question to you, along with the response options. Please choose 
the answer that appears most appropriate. If you are unsure about which response to give 
to a question, the first response you think of is often the best one.  
Please keep in mind your standards, hopes, pleasures and concerns. We ask that you think 
about your life in the last four weeks. 
 
  Very poor Poor 
Neither 
poor nor 
good 
Good 
Very 
good 
1.  How would you rate 
your quality of life? 
1 2 3 4 5 
 
  
Very 
dissatisfied 
Dissatisfie
d  
Neither 
satisfied 
nor 
dissatisfi
ed  
Satisfied  
Very 
satisfied  
2.  How satisfied are you 
with your health?  
1 2 3 4 5 
 
 
The following questions ask about how much you have experienced certain things in the last 
four weeks.  
 
  
Not at all A little 
A 
moderate 
amount 
Very 
much 
An 
extreme 
amount 
3.  To what extent do you 
feel that physical pain 
prevents you from 
doing what you need 
to do?  
5 4 3 2 1 
4.  How much do you 
need any medical 
treatment to function 
in your daily life?  
5 4 3 2 1 
5.  How much do you 
enjoy life?  
1 2 3 4 5 
6.  To what extent do you 
feel your life to be 
meaningful?  
1 2 3 4 5 
 
 Not at all A little 
A 
moderate 
Very 
much  
Extremel
y  
85 
amount  
7.  How well are you able 
to concentrate?  
1  2  3  4  5  
8.  How safe do you feel 
in your daily life?  
1  2  3  4  5  
9.  How healthy is your 
physical environment?  
1  2  3  4  5  
 
The following questions ask about how completely you experience or were able to do certain 
things in the last four weeks. 
 
  
Not at all  A little  
Moderate
ly  
Mostly  
Complete
ly  
10.  Do you have enough 
energy for everyday 
life?  
1  2  3  4  5  
11.  Are you able to 
accept your bodily 
appearance?  
1  2  3  4  5  
12.  Have you enough 
money to meet your 
needs?  
1  2  3  4  5  
13.  How available to you 
is the information 
that you need in your 
day-to-day life?  
1  2  3  4  5  
14.  To what extent do 
you have the 
opportunity for 
leisure activities?  
1  2 3 45 5 
 
 
Very 
poor  
Poor  
Neither 
poor nor 
good  
Good  
Very 
good  
15.  How well are you 
able to get around?  
1  2  3  4  5  
 
 
Very 
dissatisfie
d  
Dissatisfi
ed  
Neither 
satisfied 
nor 
dissatisfie
d  
Satisfied  
Very 
satisfied  
16.  How satisfied are you 
with your sleep?  
1  2  3  4  5  
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17.  How satisfied are you 
with your ability to 
perform your daily 
living activities?  
1 2 3 4 5 
18.  How satisfied are you 
with your capacity 
for work?  
1 2 3 4 5 
19.  How satisfied are you 
with yourself?  1 2 3 4 5 
 
20.  How satisfied are you 
with your personal 
relationships?  
1  2  3  4  5  
21.  How satisfied are you 
with your sex life?  
1  2  3  4  5  
22.  How satisfied are you 
with the support you 
get from your 
friends?  
1  2  3  4  5  
23.  How satisfied are you 
with the conditions of 
your living place?  
1  2  3  4  5  
24.  How satisfied are you 
with your access to 
health services?  
1  2  3  4  5  
25.  How satisfied are you 
with your transport?  
1  2  3  4  5  
 
The following question refers to how often you have felt or experienced certain things in the 
last four weeks. 
 
 
Never  Seldom  
Quite 
often  
Very 
often  
Always  
26.  How often do you 
have negative 
feelings such as blue 
mood, despair, 
anxiety, depression?  
5  4  3  2  1  
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Do you have any comments about the assessment?  
[The following table should be completed after the interview is finished] 
 
Equations for computing domain scores  Raw score  
  
27.  Domain 1  (6-Q3) + (6-Q4) + Q10 + 
Q15 + Q16 + Q17 + Q18  
+ + + + 
+ +  
a. =  b:  c:  
  
28.  Domain 2  Q5 + Q6 + Q7 + Q11 + 
Q19 + (6-Q26)  
+ + + + 
+  
a. =  b:  c:  
  
29.  Domain 3  Q20 + Q21 + Q22  
+ +  a. =  b:  c:  
  
30. Domain 4 Q8 + Q9 + Q12 + Q13 + 
Q14 + Q23 + Q24 + Q25  
+ + + + 
+ + +  
a. =  b:   
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The Ohio State University Consent to Participate in Research 
 
 
Study Title: 
A Pilot Study to Evaluate the Utilization of a Psychiatric 
Advanced Practice Nurse to Improve Transition Outcomes 
Principal Investigator: Tammy Moore, MS, RN, NEA-BC 
Sponsor:  Epsilon Chapter- Sigma Theta Tau International 
 
 This is a consent form for research participation.  It contains important 
information about this study and what to expect if you decide to participate.  
Please consider the information carefully. Feel free to discuss the study with your 
friends and family and to ask questions before making your decision whether or 
not to participate. 
 Your participation is voluntary.  You may refuse to participate in this study.  If 
you decide to take part in the study, you may leave the study at any time.  No 
matter what decision you make, there will be no penalty to you and you will not 
lose any of your usual benefits.  Your decision will not affect your future 
relationship with The Ohio State University.  If you are a student or employee at 
Ohio State, your decision will not affect your grades or employment status. 
 You may or may not benefit as a result of participating in this study.  Also, as 
explained below, your participation may result in unintended or harmful effects 
for you that may be minor or may be serious depending on the nature of the 
research. 
 You will be provided with any new information that develops during the 
study that may affect your decision whether or not to continue to participate.  
If you decide to participate, you will be asked to sign this form and will receive a 
copy of the form.  You are being asked to consider participating in this study for 
the reasons explained below.   
 
1.   Why is this study being done? 
 
The research team is interested in understanding how Advanced Practice Registered 
Nurses (APRN) can provide assistance to you following your hospitalization until 
your first outpatient appointment.  The team will be looking at outcomes (end results) 
related to outpatient appointment adherence (showing up for appointments), whether 
you required a readmission to the psychiatric hospital, the costs associated with the 
readmission and your quality of life. 
 
2.   How many people will take part in this study? 
 
About 50 people will take part in this study. 
 
 
 
93 
3.   What will happen if I take part in this study? 
 
All participants in the study will be asked to complete a quality of life survey at the 
beginning and end of the 30 day study and provide demographic information.  At the 
end of the study, all participants will receive a follow-up phone call to complete the 
end of study surveys and answer questions about attending their outpatient 
appointment and whether they required psychiatric inpatient readmission.   
 
You will be randomly assigned (chosen by chance; like drawing a number out of a 
bag) to either a standard of care group or an intervention group.  If you are assigned 
to the intervention group will meet with an Advanced Practice Registered Nurse 48 
and 24 hours before discharge and will be asked to respond to a phone call 24 hours 
post discharge and weekly follow-up phone calls with the APRN for 30 days or until 
their first outpatient appointment.  At day seven, the intervention participants will be 
mailed a postcard offering written support of their transition and reminding the 
participant of their upcoming outpatient appointment.   
 
If you are assigned to the standard of care group you will receive discharge planning 
as usual.  
  
4.   How long will I be in the study? 
 
Prior to any study activities you will review this form with a member of the study 
team. You will be given time review the form on your own and ask questions. This 
process is estimated to take no longer than 60 minutes. After you have reviewed and 
signed this form with a study member your participation in this study will be 30 days. 
 
5. Can I stop being in the study? 
 
You may leave the study at any time.  If you decide to stop participating in the study, 
there will be no penalty to you, and you will not lose any benefits to which you are 
otherwise entitled.  Your decision will not affect your future relationship with The 
Ohio State University.  
 
6.   What risks, side effects or discomforts can I expect from being in the study? 
 
There are minimal risks to you as the participant.  Some questions may be sensitive 
and bring up uncomfortable feelings.  You can choose to not answer these questions.  
The potential risk of a breach in confidentiality may occur but each participant will 
only be identified using a set of numbers and all study information will be locked up 
in a separate office with limited access.  
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7.   What benefits can I expect from being in the study? 
 
Benefits of the study may include that you will find contact with the research team 
helpful and for potential improvement in future health care services for the 
community. 
 
8.   What other choices do I have if I do not take part in the study? 
 
You may choose not to participate without penalty or loss of benefits to which you 
are otherwise entitled. 
 
9.   Will my study-related information be kept confidential? 
 
Efforts will be made to keep your study-related information confidential.  However, 
there may be circumstances where this information must be released.  For example, 
personal information regarding your participation in this study may be disclosed if 
required by state law.   
 
Also, your records may be reviewed by the following groups (as applicable to the 
research): 
 Office for Human Research Protections or other federal, state, or international 
regulatory agencies; 
 U.S. Food and Drug Administration; 
 The Ohio State University Institutional Review Board or Office of 
Responsible Research Practices; 
 The sponsor supporting the study, their agents or study monitors; and 
 Your insurance company (if charges are billed to insurance). 
 
If this study is related to your medical care, your study-related information may be 
placed in your permanent hospital, clinic, or physician’s office records. Authorized 
Ohio State University staff not involved in the study may be aware that you are 
participating in a research study and have access to your information.  
 
You may also be asked to sign a separate Health Insurance Portability and 
Accountability Act (HIPAA) research authorization form if the study involves the use 
of your protected health information. 
 
10. What are the costs of taking part in this study? 
 
There are no additional costs associated with participating in this study. The standard 
of care treatment will be billed to you or your insurer. 
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11. Will I be paid for taking part in this study? 
 
You will receive a $10.00 gift card for your participation in this study. By law, 
payments to subjects are considered taxable income.  
 
12. What happens if I am injured because I took part in this study? 
 
If you suffer an injury from participating in this study, you should notify the 
researcher or study doctor immediately, who will determine if you should obtain 
medical treatment at The Ohio State University Medical Center.   
 
The cost for this treatment will be billed to you or your medical or hospital insurance. 
The Ohio State University has no funds set aside for the payment of health care 
expenses for this study.  
 
13. What are my rights if I take part in this study? 
 
If you choose to participate in the study, you may discontinue participation at any 
time without penalty or loss of benefits.  By signing this form, you do not give up any 
personal legal rights you may have as a participant in this study. 
 
You will be provided with any new information that develops during the course of the 
research that may affect your decision whether or not to continue participation in the 
study. 
 
You may refuse to participate in this study without penalty or loss of benefits to 
which you are otherwise entitled. 
 
An Institutional Review Board responsible for human subjects research at The Ohio 
State University reviewed this research project and found it to be acceptable, 
according to applicable state and federal regulations and University policies designed 
to protect the rights and welfare of participants in research. 
 
14. Who can answer my questions about the study? 
 
For questions, concerns, or complaints about the study you may contact: 
 
Tammy Moore, MS, RN, NEA-BC- Principle Investigator, xxx-xxxxxx or 
Address 
Columbus, Ohio 43210. 
 
For questions about your rights as a participant in this study or to discuss other study-
related concerns or complaints with someone who is not part of the research team, 
you may contact Ms. Sandra Meadows in the Office of Responsible Research 
Practices at 1-800-678-6251. 
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If you are injured as a result of participating in this study or for questions about a 
study-related injury, you may contact: 
 
Tammy Moore, MS, RN, NEA-BC- Principle Investigator, xxx-xxxxxx or 
Address 
Columbus, Ohio 43210. 
97 
Signing the consent form 
 
I have read (or someone has read to me) this form and I am aware that I am being asked 
to participate in a research study.  I have had the opportunity to ask questions and have 
had them answered to my satisfaction.  I voluntarily agree to participate in this study.  
 
I am not giving up any legal rights by signing this form.  I will be given a copy of this 
form. 
 
 
   
Printed name of subject  Signature of subject 
   
 
 
AM/PM 
  Date and time  
    
 
 
  
Printed name of person authorized 
to consent for subject (when 
applicable) 
 Signature of person authorized to 
consent for subject  
(when applicable) 
   
 
 
AM/PM 
Relationship to the subject  Date and time  
 
 
Investigator/Research Staff 
 
I have explained the research to the participant or his/her representative before requesting 
the signature(s) above.  There are no blanks in this document.  A copy of this form has 
been given to the participant or his/her representative. 
 
 
 
  
Printed name of person obtaining 
consent 
 Signature of person obtaining consent 
   
 
 
AM/PM 
 
 
 
 
 
 
 
 Date and time  
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Witness(es) - May be left blank if not required by the IRB 
 
 
 
  
Printed name of witness  Signature of witness 
   
 
 
AM/PM 
  Date and time  
 
 
  
Printed name of witness  Signature of witness  
   
 
 
AM/PM 
  Date and time  
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November 14, 2014 
Protocol Number: 2014B0354 
Protocol Title: 
A PILOT STUDY TO EVALUATE THE UTILIZATION OF A PSYCHIATRIC 
ADVANCED PRACTICE NURSE TO IMPROVE TRANSITION OUTCOMES, 
Tammy Moore, Psychiatry and Behavioral Health 
Type of Review: 
Initial Review—Expedited 
IRB Staff Contact: 
Michael Donovan Phone: 614-292-6950 Email: donovan.6@osu.edu 
Dear Dr. Moore, 
The Behavioral and Social Sciences IRB APPROVED BY EXPEDITED REVIEW the 
above referenced research. The Board was able to provide expedited approval under 45 
CFR 46.110(b)(1) because the research meets the applicability criteria and one or more 
categories of research eligible for expedited review, as indicated below. 
Date of IRB Approval: 
November 13, 2014 
Date of IRB Approval Expiration: 
November 13, 2015 
Expedited Review Category: 7 
In addition; the research was approved for a partial waiver of HIPAA research 
authorization (recruitment only). 
If applicable, informed consent (and HIPAA research authorization) must be obtained 
from subjects or their legally authorized representatives and documented prior to research 
involvement. The IRB-approved consent form and process must be used. Changes in the 
research (e.g., recruitment procedures, advertisements, enrollment numbers, etc.) or 
informed consent process must be approved by the IRB before they are implemented 
(except where necessary to eliminate apparent immediate hazards to subjects). 
This approval is valid for one year from the date of IRB review when approval is granted 
or modifications are required. The approval will no longer be in effect on the date listed 
above as the IRB expiration date. A Continuing Review application must be approved 
within this interval to avoid expiration of IRB approval and cessation of all research 
activities. A final report must be provided to the IRB and all records relating to the 
research (including signed consent forms) must be retained and available for audit for at 
least 3 years after the research has ended. 
It is the responsibility of all investigators and research staff to promptly report to the IRB 
any serious, unexpected and related adverse events and potential unanticipated problems 
involving risks to subjects or others. 
This approval is issued under The Ohio State University’s OHRP Federalwide Assurance 
#00006378. All forms and procedures can be found on the ORRP website – 
www.orrp.osu.edu. Please feel free to contact the IRB staff contact listed above with any 
questions or concerns. 
Michael Edwards, PhD, Chair, Behavioral and Social Sciences Institutional Review 
Board 
Behavioral and Social Sciences Institutional Review Board 
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Office of Responsible Research Practices 
300 Research Administration Building 
1960 Kenny Road 
Columbus, OH 43210-1063 
Phone (614) 688-8457 
Fax (614) 688-0366 
www.orrp.osu.edu 
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THE OHIO STATE UNIVERSITY 
AUTHORIZATION TO USE 
PERSONAL HEALTH INFORMATION IN RESEARCH 
 
 
Title of the Study:  A Pilot Study to Evaluate the Utilization of a Psychiatric 
Advanced Practice Nurse to Improve Transition Outcomes 
 
Protocol Number:  2014B0354 
 
Principal Investigator:  Tammy Moore, MS, RN, NEA-BC 
  
 
 
Subject 
Name__________________________________________________________________ 
 
Before researchers use or share any health information about you as part of this study, 
The Ohio State University is required to obtain your authorization. This helps explain to 
you how this information will be used or shared with others involved in the study.   
 
 The Ohio State University and its hospitals, clinics, health-care providers, and 
researchers are required to protect the privacy of your health information.   
 You should have received a Notice of Privacy Practices when you received health 
care services here.  If not, let us know and a copy will be given to you.  Please 
carefully review this information. Ask if you have any questions or do not understand 
any parts of this notice. 
 If you agree to take part in this study your health information will be used and shared 
with others involved in this study. Also, any new health information about you that 
comes from tests or other parts of this study will be shared with those involved in this 
study. 
 Health information about you that will be used or shared with others involved in this 
study may include your research record and any health care records at The Ohio State 
University. For example, this may include your medical records, x-rays, or laboratory 
results.  Psychotherapy notes in your health records (if any) will not, however, be 
shared or used. Use of these notes requires a separate, signed authorization. 
 
Please read the information carefully before signing this form. Please ask if you have any 
questions about this authorization, the university’s Notice of Privacy Practices or the 
study before signing this form. 
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Those Who May Use, Share, and Receive Your Information as Part of This Study 
 
 Researchers and staff at The Ohio State University will use, share, and receive your 
personal health information for this research study. Authorized Ohio State staff not 
involved in the study may be aware that you are participating in a research study and 
have access to your information. If this study is related to your medical care, your 
study-related information may be placed in your permanent hospital, clinic, or 
physician’s office records.  
 
 
Initials/Date: _______________ 
 
  Those who oversee the study will have access to your information, including the 
following: 
 Members and staff of The Ohio State University’s Institutional Review 
Boards, including the Western Institutional Review Board 
 The Ohio State University Office of Responsible Research Practices  
 University data safety monitoring committees  
 The Ohio State University Office of Research.  
 
 Your health information may also be shared with federal and state agencies that have 
oversight of the study or to whom access is required under the law. These may 
include the following:  
 Food and Drug Administration 
 Office for Human Research Protections 
 National Institutes of Health  
 Ohio Department of Job and Family Services. 
 
 These researchers, companies and/or organization(s) outside of The Ohio State 
University may also use, share and receive your health information in connection 
with this study: 
 Health care facilities, research site(s), researchers, health care providers, or 
study monitors involved in this study:  Not applicable 
 Private laboratories and other persons and organizations that analyze your 
health information in connection with this study:  Not applicable 
 The research sponsor and companies owned or connected with the sponsor:  
Not applicable 
 Contract Research Organization(s): Not applicable 
 Independent data and safety monitoring boards and others who monitor the 
conduct of the study:   Not applicable 
 Others:  Not applicable 
 
The information that is shared with those listed above may no longer be protected by 
federal privacy rules. 
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Authorization Period 
 
This authorization will not expire unless you change your mind and revoke it in writing. 
There is no set date at which your information will be destroyed or no longer used.  This 
is because the information used and created during the study may be analyzed for many 
years, and it is not possible to know when this will be completed.   
  
 
 
Initials/Date______________ 
 
 
Signing the Authorization 
 
 You have the right to refuse to sign this authorization.  Your health care outside of the 
study, payment for your health care, and your health care benefits will not be affected 
if you choose not to sign this form.  
 You will not be able to take part in this study and will not receive any study 
treatments if you do not sign this form. 
 If you sign this authorization, you may change your mind at any time. Researchers 
may continue to use information collected up until the time that you formally changed 
your mind.  If you change your mind, your authorization must be revoked in writing.  
To revoke your authorization, please write to:  Tammy Moore, MS, RN, NEA-BC- 
Principal Investigator, 614- 293-7847, 1670 Upham Drive, Suite 130 Columbus, Ohio 
43210. 
 Signing this authorization also means that you will not be able to see or copy your 
study-related information until the study is completed. This includes any portion of 
your medical records that describes study treatment.  
 
Contacts for Questions 
 
 If you have any questions relating to your privacy rights, please contact:  HIPAA 
Privacy Manager, 614-293-4477, The Ohio State University Wexner Medical Center, 
600 Ackerman Road, Suite E2140, Columbus, Ohio 43202. 
 If you have any questions relating to the research, please contact:  Tammy Moore, 
MS, RN, NEA-BC- Principle Investigator, 614-293-7847 or 1670 Upham Drive, 
Suite 130, Columbus, Ohio 43210. 
 
Signature 
 
I have read (or someone has read to me) this form and have been able to ask questions. 
All of my questions about this form have been answered to my satisfaction.  By signing 
below, I permit Tammy Moore, MS, RN, NEA-BC and the others listed on this form to 
use and share my personal health information for this study.  I will be given a copy of this 
signed form. 
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Signature_______________________________________________________________  
(Subject or Legally Authorized Representative) 
 
 
Print Name _____________________________________________________________ 
Date___________ 
Time __________ AM/PM 
 
_______________________________________________ 
(If legal representative, also print relationship to subject) 
 
 
 
 
 
 
 
 
  
  
